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Fig. 1. 1. Uterus from an ovariectomised untreated 
rat (left) and from a similar animal which had received 
10 pg oestradiol subcutaneously daily for 3 days (right). 
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These investigations will deal mainly with 
oestrogenic steroid hormones, except in SECTION II where 
work with adreno -corticosteroids is reported. 
Since the isolation some thirty years ago of 
steroids which in minute amounts produce oestrus in animals 
( Doisy, Veler & Thayer, 1929; Butenandt, 1929; Marrian, 
1930), great interest has been directed towards an 
explanation for their profound biological effects. These 
effects of oestrogens in the whole animal, both gross and 
microscopio,have been the subject of numerous qualitative 
and quantitative descriptions. The anatomical changes 
produced in the uterus of the immature or ovariectomised rat 
(Bulbring & Burn, 1935; Lawson, Heller, Golden & 
Severingham, 1941; Evan, Varney & Keoh, 1941, see Fig. I. 1), 
in the chick oviduct (Hertz, 1948) and in the mammary gland 
(see Burrows, 1949a) in response to the administration of 
minute doses of oestrogen, are well recognised and easily 
discernible. In addition to the gross alterations, there 
are changes in the cellular population of some tissues 
particularly of the vaginal epithelium (Stockard & 
Papanicolaou, 1917; Allen & Doisy, 1923). 
Those tissues which respond in a striking 
manner to a hormone are commonly termed 'target' organs of 
that hormone. It is impossible at present to define just 
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what differentiates, at the cellular level, a target organ 
from other tissues of the body. There is evidence that 
enzymes from two tissues though catalysing the same reaction 
may be distinctly different and subjected to different 
degrees of hormonal control. Henion & Sutherland (1957) 
have shown, for example, that the phosphorylase of liver 
responds to glucagon, whereas the phosphorylase of muscle 
does not. 
In considering the types of mechanism by which 
oestrogen may exert their biological effects, several 
general approaches have been made. The most common working 
basis originates from the theory of Green (1941) which states 
that "any substance which in trace amount produces biological 
effects does so either by participating in, or by specifically 
affecting some enzyme systems." This hypothesis predicts 
that: 
(a) the hormone may regulate the activity of an enzyme 
system by controlling inhibitors or activators. 
(b) the hormone may function as an essential component 
of the enzyme system such as a coenzyme. 
(c) the hormone may alter the rate at which new enzyme 
molecules are produced from simpler precursors. 
In addition to this 'trace substance -enzyme' 
theory, Hechter (1955) proposes that the hormone may change 
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the permeability of the cell membrane or the membrane around 
one of the subcellular structures such as the mitochondria 
and thus make substrate or cofactor molecules more readily 
available to enzymes. 
There are at the present time few direct 
experimental data bearing upon the effects of oestrogen at 
Physiological concentration on cell permeability. Technical 
difficulty is the main obstacle to a direct approach to the 
study of this problem of hormone action at the cellular level 
(see Hechter, 1955). On the other hand, considerable 
attention has been paid to the concept that hormones exert 
their effects by acting in some way upon enzyme systems. 
The first of the two major investigations of the 
action of hormones on enzymes involves the comparison of the 
in vitro metabolism of preparations of 'target' tissues 
removed from ovariectomised animals with those taken from 
similar animals treated with physiological doses of oestrogen. 
In an important series of experiments, Mueller, Herranen & 
Jervell (1958) showed that in the rat uterus the enzymes for 
the incorporation of serine, glycine and formate into adenine 
and guanine, and those responsible for incorporation of some 
seven amino acids into proteins are increased many fold after 
in vivo administration of oestradiol -l7ß, referred to 
hereafter as oestradiol. It is noted that oestradiol has 
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little effect either on the synthesis of the pyrimidine 
bases of nucleic acids, or on the stimulation of the 
activation of thirteen other amino acids tested, thus 
indicating a certain degree of specificity of the hormone 
action. In addition to these effects Emmelot & Bosch 
(1954) have shown that oestrogen pretreatment increases the 
rate of biosynthesis of cholesterol in the mouse uterus. 
Thus the rates of biosynthesis of a number of 
important constituents of the uterine cell are increased 
by oestrogen. In reviewing his results, Mueller (1957) 
suggests that the oestrogen increases the rates of many 
enzyme systems by activating preformed enzyme molecules, and 
by increasing the rate at which enzyme molecules are produced 
de novo. 
Mueller also found that oestradiol added to 
enzyme systems in vitro is without effect. However, 
irregular increase'in the enzymic rates were obtained with 
4- hydroxy- and 2- hydroxyoestradiol, suggesting that they may 
be the 'active' forms of oestrogen (Mueller, 1955). The 
!fact that there is no oestrogen effect in vitro suggests 
that oestrogen may not have a primary role in these systems. 
The goal in studies of mechanism of action is the development 
of in vitro systems, preferably derived from 'target' organs, 
in which reproducible and measurable changes can be elicited 
by biologically active substances in physiological 
concentration. 
With this point in mind, it is not surprising 
that much attention has recently been paid to a second 
approach, the demonstration of an in vitro effect, by Villee, 
Talalay and their co- workers. Hagerman & Villee (1952, 1953) 
and Villee & Hagerman (1953) showed that the addition of 
slices 
oestradiol to human endometrium or placenta in vitro produced 
an increase in the rate of utilisation of oxygen, pyruvate 
and acetate. Upon further examination of this effect with 
a soluble preparation from human placenta, Gordon & Villee 
(1955) and Villee & Gordon (1955) showed a stimulatory effect 
of oestrogenic hormones upon the reduction of DPN (but not 
of TPN) in the presence of isocitrate. In order to explain 
these observations it was suggested that the hormone combines 
with an inactive form of a DPN- linked isocitric dehydrogenase, 
thereby rendering it enzymatically active. A kinetic 
analysis (Gordon & Villee, 1956) provides the basis for the 
enzyme activation concept. 
The observations of Villee and associates have 
been confirmed and extended by Talalay & Williams- Ashman (1958) 
who found that in more highly purified preparations of human 
placenta, the oestrogen effects disappeared but could be 
* DPN, DPNH, TPN and TPNH represent oxidised 
and reduced di- and triphosphopyridine 
nucleotides respectively. 
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restored by the addition of catalytic amounts of TPN. They 
concluded that the effect of the hormone is not upon 
isocitric dehydrogenase (reaction c) but upon a transhydro- 
genase (reaction b) as shown in the following coupled 
reactions : - 
(a) isocitrate + TPN ± a-oxoglutarate+CO2+TPNH 
(b) TPNH + DPW DPNH + TPN 
(c) isocitrate + DPN ._ a-ozoglutarate+CO2+DPITH 
Thus the locus of action of oestrogen was shifted from 
isocitrate toltranshydrogenase system. The similarities 
in properties and kinetics of the transhydrogenase and the 
oestradiol dehydrogenase of human placenta described by 
Langer & Engel (1958) led Talalay & .Williams- Äshrman to conclude 
that the two enzymes are identical. This suggests that the 
reversible oxidation and reduction of the steroids themselves 
constitutes a steroid -activated transhydrogenase system 
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Sum: DPN + TPNH _ DPNH + TPN 
This concept would place the steroid hormones, including, 
in theory, many adreno- corticosteroids and androgens as well 
as oestrogens which show the reversible change 
CO - i CHOH, 
in the position of coenzymes similar to some vitamins of the 
B complex group. However, Villee, Hagerman & Joel (1960) 
in their latest review produce evidence against the coenzyme 
theory including the fact that transhydrogenase and oestradiol 
dehydrogenases activities can be separated by electrophoresis. 
Whether the oestrogen 'activates' transhydro- 
genase as visualised by Villee, or functions as a coenzyme 
as suggested by Talalay, it is agreed that the hormone exerts 
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effects on transhydrogenase which in turn controls the flow 
of hydrogen into two sets of metabolic reactions in which di- 
and triphosphopyridine nucleotides play their specific roles. 
There is a growing realisation that DPI{ is mainly concerned 
with energy production (Kaplan, Swartz, Frech & Ciotti, 1956; 
Vignais & Vignais, 1957; Lehninger, Watkins, Cooper, Devlin 
& Gamble, 1958) whereas there are many important biological 
reductive syntheses for which TPNH serves as a specific 
hydrogen donor. These include the biosynthesis of fatty 
acids and steroids, hydroxylations, reductive carboxylations, 
and the synthesis of ascorbic acid (Horecker & Hiatt, 1958; 
Dickens, Glock & LcLean, 1959; Klingenberg & Bücher, 1960). 
Therefore the action of the pyridine nucleotide transhydro- 
genase could facilitate the capture of energy from the 
oxidation of TPNH via DPNH, and could also divert hydrogen 
flow so as to provide TPNH and thus stimulate anabolic 
processes. 
The present position appears to be that a locus 
of action of oestrogen is upon a transhydrogenase, but 
several other factors must also be kept in mind. First we 
have as yet no information concerning the quantitative 
importance of the oestrogen- activated transhydrogenase in 
the functioning of the cell. Secondly, the phenomenon has 
been investigated most thoroughly in the human placenta, a 
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tissue far from being an ideal 'model' for studying the 
mechanism of action of oestrogen. 
With these points in mind, an account is 
presented in SECTION II of this thesis of the attempt to 
demonstrate the oestrogen -activated transhydrogenase in the 
'target' organs known to show peculiar sensitivity to 
oestrogen, including the rat uterus and the chicken oviduct. 
An attempt has also been made to verify 
Talalay's "coenzyme theory" by studying the effect of 
adrenocortical steroid hormones on transhydrogenase activity 
in tissues with hydroxysteroid dehydrogenase activity. The 
steroid hormones possess groups which can undergo the change 
iC =0 ; -.CHOH 
and some of the hydroxysteroid dehydrogenases which catalyse 
these reactions have dual pyridine nucleotide specificity 
so that transhydrogenase action might proceed as follows: 
DPNH + ¡CO DPI' + ¡CHOH 
TPN + + TPNH 
sum:- DPNH + TPN DPI\ + TPNH 
In addition to the investigation of the in vitro 
effect of oestrogens on transhydrogenation, an attempt was 
made to study the effect of these substances on 
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transhydrogenation in vivo by measuring changes in the levels 
of oxidised and reduced DPN and TPN in the rat uterus after 
ovariectomy and subsequently on administration of oestrogen. 
A knowledge of the effects of oestrogenic hormones 
administered in vivo on the DPN /DPrH and TPN /TPNH ratios in 
the rat uterus might give some indication of the possible 
physiological significance of the transhydrogenation theory. 
There is evidence that concentrations of 
pyridine nucleotides in tissues are influenced by hormones. 
Thus McLean (1958) reported increases in DPN and TP1H but 
no change in DPNH or TPN concentrations in the lactating 
mammary glands of rats. The liver and diaphragm of rats 
given alloxan, growth hormone, thyroxine and thiouracil 
show changes in DPN and DPNH but little changes in TPN and 
TPNH (Glock & McLean, 1955d). Greenberg & Glick (1960) 
reported increases in concentrations of both oxidised and 
reduced forms of DPN and TPN in the adrenal glands of rats 
after the administration of adrenocorticotrophin (ACTH). 
Recently Loring, Spencer & Villee (1961) showed that there 
is no effect on the DPN /DPNH ratio in the liver, kidney 
and muscle of castrate male rats after administration of 
testosterone, but the TPN /TPNH ratio is increased in hormone 
treated animals. 
The results of determinations of DPN, DPNH, 
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TPN and TPMi concentrations in the rat uterus after 
ovariectomy and after oestradiol administration are presented 
in SECTION III of this thesis. 
In addition to the determination of pyridine 
nucleotides the quantitative activities of DPN- and TPN 
dependent dehydrogenases in the rat uterus with respect to 
oestrogenic hormonal status were investigated. In 
particular, the TPN -dependent dehydrogenases of the hexose 
monophosphate ('shunt') pathway of glucose oxidation might 
be influenced by oestrogen, since increased activity of the 
'shunt' would help to provide adequate supplies of both 
TPNH, required in many biosyntheses processes (Horecker & 
Hiatt, 1958; Dickens et al, 1959) and of ribosephosphate 
necessary in the biosynthesis of nucleotides and nucleic 
acid (see Glock & McLean, 1958). 
Oestrogen pretreatment of spayed rodents is 
known to increase the levels of many enzymes in the uteri 
e.g. ß- glucuronidase (Fishman & Farmelant, 1953), alkali 
phosphatase (Harris & Cohen, 1951), peroxidase (Lucas, 
Neufeld, Utterback, Martin & Stotz, 1955) and lactic 
dehydrogenase -DPNH oxidase (Bever, Velardo & Hisaw, 1956). 
There is evidence that hexose monophosphate 'shunt' enzymes 
are subjected to hormonal control. Thus Glock & McLean 
(1954) reported that glucose -6- phosphate dehydrogenase 
(G6PDH) and 6- phosphogluconate dehydrogenase (6PGDH) 
activities increase in the mammary glands of the rat during 
lactation. The same authors ( Glock & McLean, 1955c) found 
a decrease in 6PGDH activity in the liver of alloxan- diabetic 
rats but both G6PDH and 6PGDII activities rise after insulin 
administration. An increase of the same enzymes in the 
liver of rats treated with thyroxine was reported by Glock, 
McLean & Whitehead (1956b). Huggins & Yao (1959) find an 
increase in hepatic 6PGDH activity of gonadectomised rats of 
both sexes after 13 days oestrogen administration, but the 
activity of G6PDII is unchanged under the same conditions. 
The effects of in vivo admiiistered oestrogen 
on another important T?N- dependent enzyme, isocitric 
dehydrogenase (ICDH) and on the DPN dependent enzyme, lactic 
dehydrogenase (LDH), have also been studied for comparison 
so that it will be possible to say whether there is any 
specific oestrogen effect on the dehydrogenases of the 
hexose phosphate 'shunt'. Details of the investigation 
are presented in SECTION IV of this thesis. 
The finding that there is a selective increase 
in the activities of 'shunt' enzymes, but not of other TPI- 
dependent enzymes studied, prompted a study of the effect of 
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oestrogen on the hexosemonophosphate pathway of glucose 
oxidation. Although this pathway is of small significance 
in many tissues (e.g. muscle) compared with the glycolytic 
pathway, it has been found to be responsible for a 
significant percentage of glucose oxidation in the liver 
(see Dickens et al, 1958). It is noted that this pathway 
is especially active in tissues where rapid biosyntheses 
are taking place; examples are the lactating mammary gland 
where milk production occurs at a high rate (Abraham, Hirsh 
& Chaikoff, 1954; Glock, McLean & Whitehead, 1956a) and 
the adrenal cortex where active steroid biosynthesis is 
taking place (Kelly, Nielson, Johnson & Vestling, 1955; 
Field, Pastan, Herring & Johnson, 1960). It is therefore 
plausible that the shunt pathway might be of importance in 
the rat uterus growing rapidly in response to oestrogen. 
An additional reason for studying the effect 
of oestrogen on the hexose monophosphate shunt is the 
report of Roberts & Szego (1953) that oestrogen administered 
to the castrate rat, caused an increased glucose utilisation 
accompanied by lactate accumulation. The lactate 
accumulation however decreases markedly by the 20th hour 
after oestrogen administration while glucose utilisation 
is still increasing. This might well be interpreted as 
the take -over f±om glycolysis by the 'shunt' pathway of 
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glucose oxidation after the 20th hour. 
Accordingly the comparative significance of 
both pathways of glucose oxidation in the uterus of 
castrated and oestrogen treated rats was investigated and 
is reported in SECTION V of this thesis. 
A general discussion is found in SECTION 
VI. 
SECTION II 
ATTEMPTS TO DEMONSTRATE THE PRESENCE OF A STEROID - 
ACTIVATED PYRIDINE NUCLEOTIDE TRANSHYDROGENASE IN 
TISSUES OF ANIMALS AND HUMAN SUBJECTS. 
INTRODUCTION 
Pyridine nucleotide transhydrogenase is the 
enzyme which catalyses the transfer of hydrogen between 
pyridine nucleotides as in the equation:- 
DPN + TPIH DPEH + TPE 
The existence of this enzyme was foreshadowed 
by Ball (1942) who suggested that a flavoprotein might carry 
out this function, but it was Colov!ick, Kaplan, Neufeld & 
Ciotti (1952) who first provided the evidence for pyridine 
nucleotide transhydrogenase in Pseudomonas fluorescens. 
Since then this enzyme has been demonstrated in the 
mitochondria of many animal tissues (Kaplan, Swartz, Frech & 
Ciotti, 1956; Navazio, Ernster & Ernster, 1957; Vignais & 
Vignais, 1957; Humphrey, 1957). Humphrey (1957) reported 
that transhydrogenase occurs in the particulate fraction of 
cells of animal tissues especially heart muscle, and to a 
small extent in skeletal muscle, kidney and liver. Negligible 
activity was found in the brain, prostate, seminal vesicles, 
spleen and testis. More recently Grant & Miongkolkul (1959) 
found only negligible transhydrogenation in adrenal 
mitochondria. 
A distinguishing feature of the animal 
mitochondrial transhydrogenases is that they are not activated 
by the addition in vitro of certain oestrogens (Villee, 1955). 
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They differ thus from a second group of pyridine nucleotide 
transhydrogenases which are present in the cell sap (Villee, 
1955; Stein & Kaplan, 1959). 
These soluble oestrogen- sensitive pyridine 
nucleotide transhydrogenases, first found in human placenta, 
have already been referred to in the General Introduction 
In addition 
(p. 4-8).) Hollander, Jona & Smith (1958) were able to 
demonstrate oestrogen stimulated transhydrogenation in the 
soluble fraction of human breast tissue. However more than 
half of the specimens tested lacked the ability to respond 
to oestrogen. It was hoped that this might offer a 
diagnostic test for those breast tumours which were hormone 
dependent, but examination of an extended series of cases 
failed to give consistent results (Hollander, 1958). Hurlock 
& Talalay (1958a & b) reported that 3a- hydroxy and 3- 
oxosteroids are able to stimulate transhydrogenation in 
purified preparations of rat liver. Thus prior to the start 
of this investigation only human placenta and human breast 
tissue were shown to contain the oestrogen- activated 
transhydrogenases. Nevertheless oestrogen added in vitro 
has long been known to increase the rate of oxygen utilisation 
by many 'target' tissues. It is often quoted (Villee, 1959; 
Villee et al, 1960) that the increases in 02 consumption in 
these tissues are due to the activation of transhydrogenase 
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by oestrogen. In no case, however, has this been shown 
definitely to be due to transhydrogenase activity. Hence 
a closer examination of these tissue from 'target' organs 
is desirable. 
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PLAN OF INVESTIGATIONS 
1. The first line of investigation was an 
attempt to demonstrate the presence and quantitative 
significance of steroid -activated pyridine nucleotide 
transhydrogenase in some oestrogen 'target' organs. 
Preliminary experiments were carried out with human placenta 
as a model tissue for testing the practicability of the 
steroid- activated transhydrogenase assay, and for 
investigating the effect of certain substances on the enzyme.'. 
The substances used were 2- fluoro- oestradiol -l713, MER -25 
and amphenone -B (formulae p.p. 18 ). The strength of 
the C-F bond is known to be such that no replacement, in 
enzymatic systems, of the F by a hydroxyl group is possible 
in the first compound mentioned. An investigation of the 
effect of 2- fluoro- oestradio1 -17R on transhydrogenase in the 
human placenta is of interest in view of the postulation 
by Mueller (1955, see p.3) that hydroxylation of oestradiol 
at C -2 or C-4 may be necessary before the compound is 
biologically active. MER -25 was found by Learner, Holthaus 
& Thompson (1958) to antagonise the uterine and vaginal 
responses to oestrogen in competitive fashion, and amphenone- 
B is a non -steroidal substance with a progesterone -like 
action in inhibiting the response to oestrogen in the growth 
of hen oviduct (Hertz et al, 1955). It is therefore 
C3. CH \ 
CH CH2/ 
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interesting to know whether these oestrogen antagonists have 
any effect on the oestrogen -stimulated transhydrogenase 
system in the human placenta. 
In general, tissues were chosen for study 
according to the following criteria: - 
(a) Those which respond extremely well by 
growth or marked change in cell morphology to oestrogen 
administered in vivo. 
(b) Those which show are increase ir oxygen 
consumption, when oestrogen is added it vitro, but in which 
it has not been shown conclusively that the effect is due 
to the stimulation of transhydrogenase. 
Lost of the tissues studied belong to these 
categories. 
(c) Placentae from a number of animals were 
also examined for oestrogen- sensitive transhydrogenase 
activity in order to find if the phenomenon in this tissue 
occurs widely in mammalian species, or if it is restricted 
to man. This possibility is paralleled by the fact that 
oestriol appears to be characteristic of man, there being 
no satisfactory evidence for the occurrence of this steroid 
in other species (see i. ::errill, 1958). 
Oestradiol -17a, isolated from the urine of the 
pregnant mare (Hirschmann & Wintersteiner, 1937) and from 
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rabbit urine after oestrone administration (Stroud, 1939) 
has not so far been found in man. There would therefore 
appear to be a qualitative species difference in the way in 
which oestrone is reduced (MArrian, 1958). If 
transhydrogenase is a key enzyme in the mechanism of oestrogen: 
action it was considered to be of interest to look for this 
enzyme in rabbit placenta and to test the effect of oestradiol- 
17a on it. Oestradiol -17a is without effect on the enzyme 
from human placenta (Gordon & Villee, 1956). 
The tissues examined were the following: 
Human endometrium: This is known to undergo rapid growth 
after 1953) 
and an increase in oxygen consumption has been shown to 
occur when oestradiol is added in vitro (Villee & Hagerman, 
1952). 
Rat and guinea -pig uterus: It is well known that the uteri 
of small rodents undergo rapid growth in response to 
oestrogenic steroids administered in vivo (Bulbring & Burn, 
1935; see also Fig. I. 1). Khayyal & Scott (1931) also 
reported an increase in oxygen consumption by the uteri of 
rats or mice on addition of oestrogens in vitro. It would 
thus appear that if transhydrogenase plays any significant 
role in the mechanism of action of oestrogens it should be 
present in the uterus and its activity should be influenced 
- 21 - 
by oestradiol. 
Rat vagina: The changes in cell type in this tissue in 
response to administered oestrogen (Stockard & rapanicolaou, 
1917) form the basis of the well known vaginal smear method 
for the bioassay of oestrogens and justify the choice of 
this tissue for investigation of transhydrogenase activity. 
Chicken oviduct: This organ shows a dramatic growth response 
to oestradiol administered in vivo. Some aspects of this 
growth response have been studied by Hertz, Tullner, 
Schricker, Dhyse & Hallma (1955). 
Ox pituitary gland was chosen for study since the anterior 
lobe secretes gonadotrophin which increases oestrogen 
production, and oestrogen in turn influences the secretion 
of the anterior lobe (see Burrows, 1949b). Furthermore 
Meyer (1956) has shown that oestrogen may cause the 
development of pituitary tumours. An increase in oxygen 
consumption by pituitary tissue on adding steroid oestrogens 
in vitro has been demonstrated for the rat by Victor & 
Anderson (1938) and for man by Gaull & Villee (1959). 
Other tissues: In 1957 Humphrey reported weak 
transhydrogenase activity in the soluble fraction of rat 
spleen and heart cells but did not consider possible effects 
of steroids. This has now been investigated. 
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2. The second line of the investigation was to 
clarify the postulation that "...all (hydroxysteroid 
dehydrogenases with dual pyridine nucleotide specificity) 
function as transhydrogenases..." (Talalay & Williams - 
Ashman, 1958). The apparent identity of the placental 
transhydrogenase with oestradiol dehydrogenase, and of a rat 
liver transhydrogenase with 3a- hydroxysteroid dehydrogenase 
(Hurlock & Talalay, 1958a and b) may be quoted as examples. 
Hence it appeared to be interesting to find if other steroids 
such as those with a hydroxy group at C -11 stimulate the 
transfer of hydrogen between pyridine nucleotides in the 
adrenal and liver where the corresponding steroid - 
dehydrogenases have been demonstrated (Amelung, Hubener, 
Roka & Meyerheim, 1953; Fish, Hhyaro & Pincus, 1953). 
Similarly it appeared to be of interest to find if the 3R- 
hydroxysteroid dehydrogenase, present in the microsomal 
fraction of adreno -cortical cells (Pincus, 1958) shows any 
transhydrogenase activity. 
3. The last investigation of this Section was 
undertaken after the report by Scott & Liai (1960), that 
significant transhydrogenase activity exists in the so called 
"supernatant" fraction of the rat adrenal cells. The 
authors did not mention the possible stimulation of this 
- 23 - 
enzyme by steroids. This observation was reinvestigated 
since it appears to conflict with results already obtained 
here, and could possibly be explained by contamination of 
the supernatant fraction of Scott & Lisi with mitochondria. 
It was not originally intended to study the mitochondrial 
transhydrogenase, since it is not stimulated by steroids 
added in vitro, and is, therefore, unlikely to have a 
primary role in the mechanism of action of steroid hormones. 
Materials 
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EXPERIMENTAL 
Term placentae from women were obtained within 
an hour of delivery. Uteri were those removed surgically 
in treatment of carcinoma of the cervix, and adrenal glands 
were those removed surgically from patients with advanced 
carcinoma of the breast. Placentae of rats, guinea -pigs 
and rabbits were removed surgically in late pregnancy since 
these animals usually eat the placenta after the birth of 
the young. The placentae, adrenal glands and pituitaries 
of pigs and oxen were obtained as soon as possible after the 
slaughter of the animals. Chicken oviducts were obtained 
fresh from the Poultry Research Centre, Edinburgh. 
All tissues were transported to the laboratory 
packed in crushed ice and experiments were made without 
delay. 
Preparation of tissue homogenates 
All reagent solutions and apparatus used were 
cooled in crushed ice and all operations were done at about 
0° 
placenta: Small pieces of tissue of about 1 cubic 
centimeter volume were cut from the organ and washed 
thoroughly with physiological saline to remove blood. 
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Connective tissue was avoided as far as possible. The 
tissue was then homogenised for 1 min. with 4 -5 volumes of 
0.25 M sucrose in a Nelco Blender (Measuring & Scientific 
Equipment Ltd. (M.S.E.) London), operated at 60 volts to 
reduce the speed and hence damage to cell components. 
Human endometrium: The uterus obtained was cut in half 
longitudinally and the inner endometrium layer scraped off 
and used in making a 20% homogenate. This tissue was 
homogenised in a cone -shaped ground glass homogeniser for 
1 min. in 0.25 M sucrose solution. This method of 
homogenisation was used with all the following tissues. 
Rat and guinea -pig uterus: The uteri from adult 6-8 month 
old animals, killed by decapitation, were separated from 
adhering fat and connective tissues and slit open 
longitudinally. From three to six uteri were pooled 
together before homogenisation. Uteri from rats 
ovariectomised 2 weeks earlier were used in one experiment. 
Rat vagina: Usually when uteri of rats were removed, the 
vaginae were also kept. They were trimmed free from fat 
and connective tissues. About 6 vaginae were used in each 
experiment. 
Chicken oviduct: Four young chicks (5k-weeks old) were used 
in each experiment. Three birds were kept as a control, 
and the other was injected subcutaneously with 10 µg 
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oestradiol benzoate every second day over a period of 12 
days. Birds were then killed by breaking their necks, 
oviducts were removed and homogenised as already described. 
Ox pituitary glands: The glands were dissected from tough 
connective tissue capsules and divided into anterior and 
posterior lobes. Each part was homogenised separately. 
Human adrenal gland: The glands were freed from adhering 
blood and fat, and connective tissue was removed as far as 
possible. The whole cortical fraction was used without 
attempting further division into the different zones. The 
two glands investigated were removed from the same Patient 
in a two stage, bilateral adrenalectomy. The first gland 
weighed 5 g. The second, removed a week later after the 
patient had received 80 units ACTH intramuscularly daily 
for four days before operation, weighed 8 g. 
Ox adrenal gland: The gland was cleaned as described for 
the human gland. The medulla was srdec?_ , only the 
cortex was investigated. 
Rat adrenal gland: Whole glands were used first, and in 
one experiment the cortex was dissected away and only the 
medulla tissue was homogenised. 
Tissue fractionation 
The preparation of cell fractions was based on 
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the method of Hogeboom (1955) slightly modified. The 
homogenised tissue was centrifuged for 10 min. at 700 g. to 
remove unbroken cells and nuclei. As a result about 10% 
of the mitochondria released from the cells are sedimented 
with this fraction but as it was not desired to have a 
quantitative yield of mitochondria this is not important. 
The mitochondria were sedimented by 
centrifugation at 5,000 g. for 20 min. Normally they were 
washed once by resuspending in sucrose solution and 
homogenising for 1 min. using a round glass -bulb homogeniser 
in a well fitting plastic tube and resedimenting at 5,000 
g. for 20 min. 
The microsomes were separated from the 
supernatant fluid from the mitochondrial preparation by 
centrifuging either for 30 min. at 105,000 g. in a 
Preparative Spinco Model L Ultracentrifuge, or for 2 hr. 
at 20,000 g. in an M.S.E. Refrigerated Centrifuge with high 
speed head attachment. 
When only the soluble enzymes of the cell sap 
were required the homogenate was centrifuged once only at the, 
speed used for separating microsomes. 
The crude cell fractions were usually assayed 
without further purification, but in some cases dialysis or 
ammonium sulphate fractionations of soluble enzymes were 
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carried out. Enzymic activities were normally determined 
within one day, otherwise the enzyme preparations were 
stored overnight in a deep freeze ( -1n. This storage 
results in insignificant loss of activity of the crude 
transhydrogenase preparation from human placenta. 
Dialysis 
When dialysis was required, the enzyme 
preparations were put in a cellophane bag and dialysed 
against excess 0.25 M sucrose solution for 18 hr. in the 
refrigerator at about 40. The sucrose solution was 
changed at least once during the process. Small amounts 
of precipitates of denatured proteins appearing during 
dialysis were centrifuged down and discarded. Only the 
clear supernatants were used in the enzymic assays. 
Ammonium sulphate fractionation 
In some experiments fractionation of the 
enzymic preparations was carried out at 00 with ammonium 
sulphate. The precipitates which formed upon the addition 
of calculated amounts of the salt were collected by 
centrifugation and were dissolved in 0.01 M tris buffer 
pH 7.4. 
Nitrogen determination 
The nitrogen content of each enzyme preparation 
was routinely determined as a means of comparing different 
preparations. The nitrogen contents of supernatant 
fractions are also a good indication of the completeness 
of the homogenisations. For the determination, samples 
dialysed to remove sucrose were digested with sulphuric 
acid containing a mercury catalyst, followed by direct 
hesslerisation (Le Page, 1957). 
Enzymic determinations 
Two methods had been employed in the 
determination of pyridine nucleotide transhydrogenase. 
(a) Snectrophotometric method. 
This method was based on that of Gordon_ & 
Villee (1956). Full details of the reactants are shown 
under Fig. II. 1. Briefly, the incubation mixture contains 
excess DPN and a TPN reducing system, having substrate 
(isocitrate or glucose -6- phosphate) and corresponding 
dehydrogenase present in excess. Only catalytic amounts 
of Tipr are present. The only limiting step is thus the 
transfer of hydrogen from TPNH to DPN. This is measured 
as an index of transhydrogenase activity. The formation 
of reduced DPN is followed by measuring the increase in 
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optical density at 340 mµ, using the Unicam SP500 
spectrophotometer. A special copper container with 4 
compartments, designed to take the 1 cm. silica cuvettes 
used, was made so that the cuvettes could be maintained at 
desired temperatures in a thermostat and removed for short 
periods in order to measure optical densities. It was found 
that incubation at 370 increased the activity of human 
placental transhydrogenase by two fold over the value found 
at room temperature (200). However, room temperature 
incubations were employed for heat labile preparations such 
as those of the rat uterus. Otherwise the precipitation 
of protein interfered with the optical measurements. 
After the incubations, alcohol dehydrogenase 
and acetaldehyde were usually added to the mixture to test 
if the increase in the optical density was in fact due to 
DPNH production. Alternatively when no increase in optical 
density was observed alcohol dehydrogenase plus ethanol were 
added to the system to check that DPN was still present in 
appreciable quantity and that the negative results were not 
caused by destruction of this coenzyme. 
(b) a- oxoglutarate determination. 
This method for transhydrogenase assay was not 
used as extensively as the spectrophotometric method. The 
reason for introducing it was to confirm the results obtained 
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spectrophotometrically, especially in cases where the enzyme 
preparations were heat labile and became turbid after long 
incubations thus preventing accurate optical measurement. 
The reaction mixture is the same as for the spectrophoto- 
metric method (full details under Fig. II. 1), but 
isocitrate only is used in generating TPEH. The rate of 
formation of a- oxoglutarate from isocitrate, which is 
measured, depends on the rate of the reoxidation of TPNH 
to TPN in which the activity of transhydrogenase is the 
governing factor. a- oxoglutarate is determined by the 
method of Friedemann & Haugen (1943) as used by Loring & 
Villee (1957). 
The addition of steroids 
Crystalline steroids were initially dissolved 
either in propylene glycol or dioxane. Both solvents were 
found to be equally suitable for use with the human 
placental enzyme system. It was found, however, that 
propylene glycol could be reduced by a rat liver soluble 
enzyme requiring DPN as coenzyme and thus interfered with 
the optical method of assaying transhydrogenase. Although 
many other tissues, including human placénta, are devoid of 
such a "propyleneglycol dehydrogenase," dioxane, which is 
not metabolised in this way, was used as a solvent for 
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steroids in all subsequent investigations. 
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RESULTS 
(a) Experiments on human placenta 
In preliminary experiments it was possible to 
confirm that oestradiol and oestrone greatly stimulate the 
transhydrogenase activity, oestriol has only a very slight 
effect while oestradiol -17a has none. The result of a 
typical spectrophotometric assay of transhydrogenase in a 
human placental preparation is shown in Fig. II. 1, and 
that of an a- oxoglutarate determination is shown in Fig. 
II. 6. 
The fraction of the soluble placental enzyme 
preparation precipitated by 40% saturation with ammonium 
sulphate also showed oestrogen -sensitive transhydrogenase 
activity (Fig. II. 2) and was found to require minute 
amounts of TPh as described by Talalay & Williams- Ashman 
(1958). (The crude preparations do not require added TPN). 
The presence of DPN- and TPN- linked oestradiol dehydrogenase 
was also demonstrated in the purified fraction (Fig. II. 3). 
As an extension of the study of the human 
placental transhydrogenase reported by others, the effects 
on the enzyme of certain less common steroids and of 
oestrogen antagonists were studied. Fig. II. 4 shows 
that 2- fluoro -oestradiol -l7í is as effective as oestradiol 
O 8 
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Fig. II. 1. Effects of oestradiol, oestriol and ib a- 
hydroxyoestrone on transhydrogenase activity in the crude 
human placental preparation. The 3 ml final volume 
incubation mixture contained 100 mM of tris buffer, pH 7.4; 
3 mM of MnC12; 2 mM of DL- isocitrate; 0.25 mM of DPN and 
1 ml of the enzymic extract (containing 1 mg N2 per ml). 
10 pg of steroid (final concentration 1.3 X 10 -DM) was 
added when indicated. Blank cell was devoid of DPN. The 
decrease in the optical density when alcohol dehydrogenase 
and acetaldehyde were added at 70 min. confirmed that the 
original rise in the absorbance at 340 mp was due to DPEH 
produced. (If it is not otherwise stated, the incubation 
mixture used in the following Figures in Section II contain 
the same reaction mixture as above). 
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Fig. II. 2. Demonstration of steroid activated transhydrogenase. 
The enzyme preparation was the fraction of a human placental 
cell sap preparation precipitated by 40% saturation with 
ammonium sulphate. Both TPN (4 X 10-6 M) and oestradiol 
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Fig. II. 3. Demonstration of DPN- and TPN -linked oestradiol 
dehydrogenase in human placenta. The enzyme preparation was 
the fraction of a human placental cell sap preparation 
precipitated by 40% saturation with ammonium sulphate. The 
incubation mixture contained 0 mM Na3HP207 buffer, (pH 9), 
20 mg human serum albumin,l0 1 oestradiol and 0.25 mM DPN or 
TPN. The blank cell contained all components other than 
DPN or TPN. Enzyme preparation added contained 0.14 mg N2. 
Final volume was 3 ml. 
03 
02 
-A.--1- 2 -FLUOROOESTRADIOL - --111- OESTRADIOL 
0 20 40 60 80 
TIME ( MIN.) 
Fig II.4. The effect of oestradiol and 2- fluorooestradiol on 
human placental transhydrogenase. Reaction mixture as in Fig. 
II. 1. 
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in the stimulation of placental transhydrogenase. 
MER-25 (in concentrations up to 8 X 10-5M) 
and amphenone -B (in concentrations up to 10 X 10 3M) do not 
inhibit the transhydrogenase system (Figs. II. 5, II. 6 & 
II. 7). HER - 25 is not readily soluble in water or the 
incubation mixture and the concentration of 8 X 10-5M 
(100 µg per 3 ml.) is almost the maximum which can be 
obtained. 
(b) Attempts to demonstrate steroid activated 
transhydrogenases in the soluble fraction of cells from 
human and animal tissues. 
From the results summarised in Table II. 1, it 
may be seen that not all tissues contain demonstrable 
transhydrogenase activity. Details of the results are as 
follows: 
(i) Tissues which respond sensitively to 
oestrogen administered in vivo, and /or tissues which 
give an increase in oxygen consumption when oestrogen 
is added in vitro. 
Human endometrium: 
Two experiments have been performed using the 
endometrium crude soluble fraction. No 
transhydrogenase activity could be detected by the 
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o 30 GO 
TIME (MIN.) OF INCUBATION 
90 
Fig. II. 6. Effect of adding oestradiol (OD) and MER -25 
on transhydrogenase activity as measured by a- oxoglutarate 
method. The reaction mixture contained the same reactants 
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or presence of oestradiol, oestrone or oestriol. 
Rat and Guinea -pig uterus: 
In ten experiments with rat uteri (including 
one with uteri from ovariectomised rats) and in one 
with guinea -pig uterus, only negligible activity of 
transhydrogenase could be detected and this was 
uninfluenced by oestradiol or oestriol. 
The uterine extracts were rather heat labile 
and appreciable denaturation occurred during 
incubation at 37 °. This interfered with optical 
measurements but the interference could be decreased 
by making the measurements at 20 °. When the 
a- oxoglutarate method was used in attempts to detect 
the activation of transhydrogenase by oestrogen the 
results obtained were again negative. 
These negative results may be due to the 
presence of an inhibitor in the rat uterine 
preparation. In order to investigate this the rat 
uterine preparation was added to an active human 
placental preparation. Results in Fig. II. 8 show 
that there is a decrease in transhydrogenation, the 
extent of which depends on the amount of uterine 
extract in the mixture. The rat uterine preparation 
may thus contain an inhibitor of transhydrogenation. 
O-1 
-- -- I ml. HUMAN PLACENTAL ENZYME 
A À 
I Ml. HUMAN PLACENTAL ENZYME 
PLUS O.1 rd. RAT UTERUS ENZYME 
I ml. HUMAN PLACENTAL ENZYME 
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Fig. II. 8. The inhibiting effect on the human placental 
oestradiol- activated transhydrogenase when different amounts 
of rat uterine preparation were present. 
- 36 - 
Dialysis of the uterine preparation did not remove 
the inhibitory effect. 
Rat vagina: 
In four ekperiments carried out with rat vagina, 
transhydrogenase activity was not found either in the 
absence or presence of oestradiol. Oestriol, which 
stimulates development of cervix, vagina and vulva 
more effectively than oestrone or oestradiol (see 
Merrill, 1958), is also without effect. 
Hen oviduct: 
The average weight of the oviduct from 5i week 
old chicks in the present experiments was 33 mg., 
while the weight of this organ from oestradiol benzoate 
injected chicks rose to 1.8 g. Transhydrogenase 
activity could not be detected either in the control 
or oestrogen treated oviducts, nor did this enzyme 
activity appear after addition of oestradiol in vitro. 
When an oviduct preparation was mixed with the human 
placental enzyme, inhibition of the placental 
transhydrogenase occurs (Fig. II. 9). 
Ox pituitary glands: 
Experiments were performed with two separate 
samples of ox anterior pituitary glands and one with 
the posterior lobe. In neither case was 
(Al HUMAN PLACENTAL PREPARATION 
0'3 - (C) + (3) 
(B) --- chick oviduct preparation 
0 20 40 60 
TIME (MIN.) 
80 100 
Fig. II. 9 . The inhibition of human placental oestradiol- 
activated transhydrogenase by the chick oviduct preparation. 
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transhydrogenase activity demonstrated and neither did 
oestradiol nor oestriol bring about the appearance of 
any activity. 
(ii) Transhydrogenase activity in placentae 
of various species. 
Preparations from the placentae of rat (1 
experiment), rabbit (1 experiment), golden hamster 
(2 experiments), quinea -pig (4 experiments) and pig 
(1 experiment) were investigated. "Soluble fraction" 
transhydrogenase activity was not found in any of 
these tissues, either in the absence or presence of 
oestradiol or of oestradiol -17a in the case of the 
rabbit placental preparation. Typical results 
obtained with a preparation from hamster placenta are 
shown in Fig. II. 10. One positive result was 
obtained in the case of guinea -pig placenta, but this 
could not be repeated using either the spectrophoto- 
metric or the u- oxoglutarate method. 
An inhibitory effect on the activity of the 
human placental transhydrogenase occurs when any of 
the inactive placental preparations are added (Fig. 
II. 11). The degree of inhibition depends on the 
amount of the latter preparation in the reaction 
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ADH + E t OH 
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Fig. II. -10. The absence of transhydrogenase activity and 
lack of effect of oestrogens in hamster placental preparation. 
The increase in optical density after the addition of alcohol 
dehydrogenase and ethanol at 120 min. indicates that there 
was still an excess of DPN at the end of the incubation. 
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Fig. II. 11. The inhibiting effect of the rat placental 
preparation on the oestradiol- activated transhydrogenase of 
the human placental preparation. 
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placental preparation was found to be devoid of the 
inhibitory effect. 
(iii) Other tissues. 
Rat spleen and heart: 
As observed by Humphrey (1957) only weak 
transhydrogenase activity was found in the soluble 
fraction of cells from rat heart and spleen. This 
was uninfluenced by added oestradiol or oestriol. 
(c) Attempts to demonstrate steroid -activated 
transhydrogenase in microsomal and soluble fractions of 
cells from tissues containing hydroxysteroid dehydrogenases 
with dual pyridine nucleotide specificity. 
Rat liver: 
Only negligible transhydrogenase activity was 
found in microsomal and soluble fractions of rat liver cells. 
Addition of the 11P- hydroxysteroidprcortisol, was without 
effect. 
Human, ox and rat adrenal cortex: 
It has not been possible in the present 
investigation to demonstrate transhydrogenase activity in 
either the microsomal or the soluble fraction of 
adrenocortical tissue from rat,ox or human subjects. 
Cortisol (1lß- hydroxysteroid), pregnenolone (3p- 
hydroxysteroid) and oestradiol (17p- hydroxysteroid) were 
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without effect. A typical result with added oestradiol 
is shown in Fig. II. 12. 
(d) Mitochondria) transhydrogenase in the 
adrenal glands. 
On repeating Scott & Lisi's experiments (Scott 
& Lisi, 1960) an active transhydrogenase was found in the 
supernatant fluid, obtained on centrifuging rat adrenal 
homogenate at 2,200 g. for 1 hr. However, when the 
preparation was centrifuged further at 20,000 g. for 1 hr., 
the transhydrogenase had completely disappeared (Fig. II. 13). 
Furthermore, when another preparation of rat adrenal 
homogenate was subjected to differential centrifugation, 
the transhydrogenase activity was found to reside in the 
mitochondrial fraction only, and not at all in the microsomal 
plus the soluble fractions. The mitochondrial enzyme is 
stimulated neither by oestradiol nor by cortisol. No 
transhydrogenase activity was found in the supernatant 
fluid of a rat adrenal medulla homogenate centrifuged at 
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Fig. II. 12. The absence of transhydrogenase activity in the soluble 
fraction of an ox adrenocortical preparation. The slight nonspecific 
increase in the optical density occurred even when DPI` was not present. 














FOR I hr 
ADH +CH3CHO 
20 40 60 80 100 
TIME (MIN) 
120 140 160 
Fig. II. 13. Demonstration of transhydrogenase activity in the rat 
adrenal preparation obtained after centrifuging the 20% homogenate at 
2,200 g. for 1 hr. However when this preparation was certrifuged 
further (20,000 g. 1 hr), the transhydrogenase activity disappeared 
completely. The 3 ml. final volume incubation mixture contained 50 
mM tris buffer, pH 7.4; 1.7 mM G6P; 0.1 -0.2 ml. adrenal preparations. 
0.25 mM DPN and .01 mM TPN were added when indicated. The amount of 
TPN used, when fully reduced, corresponds to an optical density of 0.06 
unit at 340 mµ. The blank cell contained no pyridine nucleotides. 
Alcohol dehydrogenase and acetaldehyde were added at the end of the 
experiment to demonstrate the presence of DPNH. 
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DISCUSSION 
All attempts to demonstrate the presence of a 
soluble oestrogen -activated transhydrogenase in the well 
known oestrogen 'target' tissues of many animals have been 
negative. DPN and substrate (glucose -6- phosphate, or 
isocitrate) were always shown to be present in excess at 
the end of each negative transhydrogenase determination, 
as seen by the sharp rise in the optical density at 340 mµ 
when alcohol and alcoholdehydrogenase, or TPN were added to 
the incubation mixture. This addition of TPN did not, 
however, stimulate any DPNH production. It is, therefore, 
unlikely that the absence of transhydrogenase activity 
observed in the present investigation was due to the 
destruction of substrate or coenzymes during the experiment. 
The failure to stimulate transhydrogenase activity by 
oestrogen in the rat uterus, human endometrium, and the 
pituitary gland of the ox, even though increases in the 
oxygen consumption on adding oestrogen have been observed 
in these tissues, indicates that some other enzyme (or 
enzymes) is primarily activated by the oestrogen added 
in vitro. (The possibility that the oestrogen effect on 
oxygen consumption is a permeability phenomenon cannot, 
however, be excluded.) The enzyme or enzymes concerned 
may be those we already know, such as the enzymes of 
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carbohydrate, fat, or protein metabolism in the final part 
of which oxygen is being consumed via the citric acid 
cycle and the cytochrome system. On the other hand, it 
may be a new enzyme not yet familiar to us. The 
identification of the enzyme(s) concerned should merit 
further investigation as it would be of much value in the 
study of the mechanism of action of oestrogen. 
Transhydrogenase appears to be the key enzyme in the human 
placenta. The possibility of stimulating oxygen 
consumption in the rat vagina and chicken oviduct by 
oestrogen has not yet been investigated. Whether these 
tissues also possess the same type of oestrogen- sensitive 
enzyme as discussed above, is again a matter for further 
investigation. 
Many of the effects of oestrogen on animal 
tissues, such as those shown by Mueller and co- workers 
(Mueller et al, 1958) and in the present investigation 
(SECTION IV), have been observed some hours after oestrogen 
administration in vivo, while there is no effect if the 
oestrogen is added in vitro. However, the absence of 
transhydrogenase activity in the chick oviduct from control 
and oestrogen treated birds indicates that this enzyme 
activity does not appear on treatment with oestrogen. (A 
further attempt to demonstrate the effect of oestradiol 
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administered in vivo on uterine transhydrogenation was made 
by studying the ratios of oxidised and reduced DPN and TPN. 
The results of this study are presented in SECTION III of 
this thesis). 
The absence of an oestrogen -activated 
transhydrogenase in the placentae of rat, guinea -pig, hamster 
and pig, confronts us with another example of species 
differences. These five species with no active 
transhydrogenase on the one hand and the human with an 
active enzyme on the other. The lack of stimulation by 
oestradiol -17a in the rabbit placenta is perhaps not 
unexpected in view of the inability of oestradiol -17R to 
stimulate transhydrogenation. 
The inhibition of human placental 
transhydrogenase by the preparations from rat uterus, 
chick oviduct, and from placentae of rat, guinea -pig, rabbit 
and pig shows that the apparent absence of transhydrogenase 
in these tissues may be due to the presence of an inhibitor. 
Talalay, Hurlock & Williams- Ashman (1958) stress the 
importance of the DPN /TPN ratio in the incubation mixture 
used to study transhydrogenase activity,because high TPN 
concentration (above 10-5M) inhibits the enzyme markedly. 
Hence TPN in a bound form (dialysis did not remove the 
inhibition) may be the inhibitor. However, the amount of 
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TPN in the oxidised and reduced state is found to be low 
in the rat uterus (see SECTION III of this thesis), in the 
rat placenta ( Glock <dcLean, 1955b) and in the human 
placenta (Villee, Joel, Loring & Spencer, 1960). In the 
3 ml. incubation mixture containing either preparations of 
human placenta and rat uterus, or human and rat placentae, 
the total oxidised and reduced endogeneous TPN can be 
calculated to be between 1 and 5 X 10 
76 
M which is below 
the critical concentration of 10-5M. Hence it is unlikely 
that the inhibition of the human placental transhydrogenase 
is caused by the endogeneous triphosphopyridine nucleotide/ 
in the preparations. Since the inhibitory property of 
guinea -pig placentae preparation was lost after boiling, 
the nature of inhibition may be enzymic. The fact that 
dialysis does not remove the inhibitory effect in these 
preparations also indicates that large (protein ?) molecules 
may be involved in the inhibiting process. The nature of 
the inhibitor(s), is at present unknown. This is another 
interesting topic for future investigation. 
The observation that 2- fluoro -oestradiol -17ß 
is as effective as oestradiol in the stimulation of human 
placental transhydrogenase rules out the possibility that 
a 2- hydroxy derivative is the active substance in this 
system. 
-44- 
Substances antagonising oestrogenic responses 
in vivo' might well be expected to inhibit oestrogen action 
in vitro especially if these in vitro systems are of 
physiological significance. However, well known oestrogen 
antagonists such as MMER -25 and amphenone-B are found to be 
without inhibitory effect upon the activity of oestradiol- 
activated placental transhydrogenase. The lack of oestrogen 
antagonising effect of amphenone -B may, however, be explained 
by the fact that this compound was found by Hertz (1958) to 
interfere with corticosteroid biosyntheses in the adrenals 
resulting in the production of progesterone -like substances, 
which may be the true in vivo oestrogen antagonists. 
In general it would appearAthere is 
negligible transhydrogenase activity in the soluble fraction 
of cells of the tissues studied. The active transhydrogenase 
found in the 'supernatant' of rat adrenal preparation by 
Scott & Lisi (1960) has been shown here (p. 39) to be of 
mitochondrial origin. 
The inability of an 11- hydroxysteroid (cortisol) 
to stimulate transhydrogenation in the rat liver, rat and 
ox adrenal glands, and of a 3G- hydroxysteroid (pregnenolone) 
to have the same effect in the rat and ox adrenal glands, 
although these tissues possess the relevant steroid 
dehydrogenase activity, shows that these steroids do not 
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in fact function as coenzymes as suggested by Talalay and 
co- workers. Such observations lend support to the view 
that the oestrogen -activated transhydrogenase and the 
oestradiol dehydrogenase in human placenta are indeed 
separate and distinct enzymes. This idea has been advanced 
by Villee and co- workers (Villee, Hagerman & Joel, 1960) 
who recently summarise a long list of the differences in 
the properties of the two enzymes. Besides numerous 
differences towards inhibitors and heat inactivation, the 
most convircing evidence is that the transhydrogenase and 
dehydrogenase activities can be separated by electrophoresis 
on a starch block and by continuous flow paper curtain 
electrophoresis (Hagerman & Villee, 1959). Therefore, 
judging from present evidence, Talalay's coenzyme theory 
where steroids are visualised as hydrogen carriers similar 
to the concept of the functions of some vitamins, cannot 
be accepted without further modification or new supporting 
evidence. This is rather unfortunate because the 
speculation is the first of its kind to offer an explanation 
of how a hormone may work at molecular level. 
A fuller discussion of the transhydrogenase theory 
and the mechanism of action of oestrogens in the light of 
results reported in this Section and in Section III is to 
be found in the General Discussion (SECTION VI). 
SECTION III 
THE E1u CT OF OESTRADIOL ON THE CONCENTRATIONS OF 
OXIDIZED AND REDUCED DPN AND TPN IN THE RAT UTERUS. 
-46- 
INTRODUCTION 
In SECTION II an attempt was made to demonstrate 
transhydrogenase activity in oestrogen -sensitive tissues and 
to show an in vitro effect of oestrogen on this enzyme. 
Failure to demonstrate this enzyme activity might be due to 
its loss during handling of the tissues, to an unsatisfactory 
assay procedure for the particular tissue concerned or to the 
presence of an inhibitor. An alternative approach might be 
to attempt to show changes in the proportions of oxidised and 
reduced DPN and TPN in the tissues which might be due to 
the effect of transhydrogenase influenced by oestrogen 
administered in vivo. It is possible to compare the ratios 
DPN /DPNH and TPN /TPNH in oestrogen sensitive tissues from 
castrated animals with and without administration of oestrogen., 
A transfer of hydrogen from DPNH to TPN would cause an 
increase in DPN /DPNH with a corresponding decrease in TPN /TPIH'. 
and similarly a transfer of hydrogen from TPNE to DPN would 
cause the opposite change in the ratios. Either change 
might be taken as an indication of transhydrogenase activity. 
Thus a possible effect of oestrogen might be investigated by 
a study of changes in these ratios. 
The influence of hormones on pyridine nucleotide 
concentrations is considered in the General Introduction 
(p. 9 -10). It is of interest to find if oestrogens have 
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any effect on the concentrations of these important coenzymes 
in the 'target' organs. This information may be useful 
in understanding how the hormone works in these tissues. 
-48- 
PLAN OF INVESTIGATIONS 
The rat uterus, by virtue of its dramatic 
response to oestrogen administered in vivo (see Fig. I. 1), 
was chosen for this investigation. 
It was necessary to determine the concentrations 
of DPN, DPNH, TPN and TPNH in the uteri of rats belonging to 
the following groups:- 
(i) 'normal' or intact 
(ii) ovariectomised 
(iii) ovariectomised and injected with oestradiol 
In this way it was hoped to compare the changes, 
if arty, in the concentrations of the four forms of coenzymes 
following castration, and after treatment of castrated animals 
with oestrogen. 
Intact rats used in the present investigation 
(Sections II, III, IV and V) were chosen at random, without 
any attempt to establish the phases of their oestrous cycle. 
It was assumed that, with a reasonable number of animals, 
values (for pyridine nucleotide concentrations, enzyme levels, 
etc.) obtained for this group of animals can be taken as the 
mean values for animals between the two extreme phases, 
;oestrus and dioestrus. These mean values (described as 
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'normal' rat values), together with their variations, are 
assumed to represent the ranges of levels of enzymes and 
coenzymes, etc. normally occurring in the average intact 
rats. At most, however, they can be considered only as a 
guide when comparing with values obtained from animals 
artificially created as oestrus and dioestrus by ovariectomy 
with and without oestrogen administration. 
-50- 
E7PERIURTTAL 
Animals and Operations 
The white Wistar rats used were 3 to 6 months 
old and weighed about 200 g. They were ovariectomised under 
ether anaesthesia and left 2 -4 weeks before experiments. 
Small pieces of uterine horns were removed with the ovaries to 
ensure complete ovariectomy. 
Injections 
For subcutaneous injections, oestradiol was 
dissolved in small amount of ethanol (1 mg /ml) and diluted 
with sesame oil to give the concentrations required. Animals 
were given three daily injections of 1 µg oestradiol in 0.1 
ml volume, and they were killed 72 hours after the first 
injection. For intravenous administration a solution of 
100 µg oestradiol /ml was prepared in physiological saline 
according to Roberts & Szago (1947). In each case a single 
dose of 10 µg was injected in a volume of 0.1 ml into either 
the tail, femoral or jugular vein. The animals were killed 
after periods stated in text. 
Preparation of tissues 
Rats were killed by breaking their necks and the 
uteri quickly removed following an incision at the fundus. 
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Thus uterine horns but not corpus were used in the 
experiments. Adhering fat and connective tissues were 
removed with the uterus lying on a tile chilled on ice. 
The uterus was slit open lengthwise with scissors, blotted 
with filter paper and weighed in a precision type torsion 
balance. A piece of the uterine tissue chosen at random 
was reserved for dry weight determination. 
Dry weight determination 
Pieces (about 20-25 mg) of uterine tissue were 
blotted, weighed on a torsion balance (correct to 0.2 mg) 
and placed on a small piece of dried, weighed tin foil kept 
in a desiccator. It is important to weigh the uterus very 
soon after removing fat and connective tissues since water 
from the small piece of tissue evaporates considerably even 
when the tissue is sitting on ice. The tissue on tin foil 
was then left in an oven at 1100 for 24 hours, at the end of 
which it was allowed to cool to room temperature in a 
desiccator before being reweighed. The percent dry weight 
of the uterus was then calculated. 
Selection of the method of determination of the pyridine 
nucleotides 
DPN, discovered by Harden & Young (1906) and 
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TPN by Warburg & Christian (1931), have been shown to occupy 
a special place among the catalysts of biological oxidation. 
While these substances have been isolated and purified, and 
their structure and biochemical roles determined, a convenient 
and satisfactory method of measuring the oxidised and reduced 
forms in animal tissues has yet to be found. An apparently 
reliable, if rather laborious, method has been available 
since 1955 (Glock & McLean, 1955a). In this enzymic method 
the reduced coenzymes are coupled with their respective 
cytochrome c reductases and the rate of reduction of a pool 
of cytochrome c is followed spectrophotometrically. As 
little as 3 X 10 
-7 M can be measured by this method. 
A second method by Jacopson & Astrachan (1957) 
is based on the measurement of fluorescence of the pyridine 
nucleotides developed by concentrated alkali solution. The 
lowest concentration that can be measured is reported to be 
108M. 
Bassharn, Birt, Hems & Loening (1959) developed 
another fluorimetric method for the determination of the 
oxidised and reduced pyridine nucleotides with sensitivity 
down to 1.5 X 10 
-6 
M or lower. The advantage of this 
fluorimetric method, over that of Jacopson & Astrachan (1957), 
is that the preparation or expensive purchase of some five 
enzymes is avoided. 
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After the present investigation was finished, 
a fourth method, a modification of that of Glock & McLean 
(1955a), was presented by Villee (1961). In this, the 
difficulty of the preparation of DPNH- and T?IH- cytochrome 
c reductases is overcome by the use of commercially 
available diaphorase and the reduction of 2:6 
dichlorophenolindophenol instead of the more expensive 
cytochrome c is measured. However the full procedure and 
the sensitivity of the method have yet to be published. 
At the beginning of this investigation much 
time was devoted to finding a suitable method for the 
extraction and determination of oxidised and reduced DPP- 
and TPN. The method of Glock & McLean (1955a) was tried 
first. TPNH -cytochrome c reductase was prepared from 
Younger's Top Ale brewer's yeast by the method of Haas, 
Horecker & Hogness (1940) as modified by Glock & McLean 
(1955a). A darkish -brown precipitate was obtained and 
found to contain 2 units /mg of the reductase activity. It 
was devoid of DPNH- cytochrome c reductase activity. The 
enzyme was quite stable at -15 °. The preparation of DPNH- 
cytochrome c reductase from pig hearts followed the method 
of Mahler, Sarkar, Vernon & Alberty (1952) modified by 
Glock & McLean (1955a). Although Hems & Villee (private 
communications) both had much difficulty in the preparation 
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of this enzyme, a fairly active preparation containing 
12 -16 units /ml was obtained. This, however, was rather 
unstable. In one case, only 10% of the enzymic activity 
remained after 5 weeks storage at -15 °. Owing to the very 
tedious preparation of the enzyme and its instability this 
procedure is rather unattractive. 
Another difficulty that arose unexpectedly, 
was that some impurity in the cytochrome c used (purchased 
from Lights & Co.) was precipitated by rat tissue extracts, 
especially with the alkali extract. This interfered 
seriously with accurate optical density measurements. The 
problem was solved by using a more expensive but purer 
preparation of cytochrome c obtainable from Sigma & Co., 
or could possibly have been solved by direct preparation of 
the substance from horse heart (Keilin & Hartree, 1952, as 
modified by Margoliash, 1954). These solutions are again 
not too attractive due to the high cost of the purchased 
material or of time and effort needed to prepare the highly 
purified material, or to recover it, as suggested by Glock 
& McLean (private communication). In view of these 
difficulties this method was not proceeded with. 
Method finally chosen 
The method of Bassharn, Birt, Hems & Loening 
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(1959) was then tried in preference to that of Jacopson & 
Astrachan (1957) in view of the fact that many enzymes 
needed to be prepared in the latter method. Since they are 
based on the same principle of measuring fluorescence 
produced on incubating the coenzyme with concentrated alkali, 
the sensitivity of the two procedures should be comparable. 
The method of Bassharn et al (1959) was found to work 
satisfactorily in the author's hands and therefore it was 
employed in the determination of pyridine nucleotides in the 
rat uterus with a few minor modifications. 
Only an outline of the procedure, with the 
modifications adopted, is given here. 
Extraction of coenzymes: 
It was found easier to grind tough uterine 
tissue in conical shaped glass homogenisers with conical 
pestles in place of the usual cylindrical type of apparatus 
(Potter & Elvehjem, 1936). Two homogenisers with pestles 
were heated in a boiling water bath for at least 5 minutes. 
One contained the "acid medium" (2.5 ml of 0.1 M 2- amino -2- 
hydroxymethylpropane -1:3 -diol (tris) buffer pH 8.2, 1 ml 
H2O and 0.5 ml N.HC1) for extracting DPN and TPN, the other 
the "alkaline medium" (2.5 tris buffer, 1 ml H2O and 0.5 ml 
N.NaOH for extracting DPIVH and TPNH. Portions of uterus, 
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sometimes from a pool of tissue, weighing 100 -200 mg were 
dropped into the hot extraction solutions. After 30 seconds 
the homogenisers were removed from the bath, the contents 
ground for 11- minutes, while still hot, and then immersed in 
a bath of acetone -solid CO2 until the contents were frozen. 
The contents were subsequently thawed, pH adjusted to 8.2 
and volumes to about 5.0 ml. After centrifuging for 15 
minutes at 0o and 20,000 g. the clear supernatant solutions 
(referred to as the "Acid" and "Alkaline Extracts ") 
containing the pyridine nucleotides were removed and treated 
further without delay. 
Fluorimetric measurement: 
Solutions of glucose -6- phosphate (G6P), 
glucose -6- phosphate dehydrogenase (G6PDH), alcohol 
dehydrogenase (ADH) and approx. NT HC1 and N -NaOH were 
prepared according to Bassham et al (1959). On account of 
the low pyridine nucleotide content of the rat uterus, it 
was found necessary to modify the sodium hydroxide- hydrogen 
peroxide solution in order to minimise the dilution of the 
pyridine nucleotide solution. This solution was prepared 
immediately before use by adding 0.16 ml 3% (W /V) hydrogen 
peroxide to 3.0 ml 15 N -NaOH. A standard solution of 
3 µIQ DPN was prepared in 0.03 M tris buffer pH 8.2. 
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A 2 ml volume of the "Acid Extract ", containing 
DPN and TPN was mixed with 0.05 ml G6PDH and 0.05 ml G6P 
and kept at room temperature for 20 minutes. The product 
(Solution A) now contains DPN and TPIH. 
A 2 ml volume of the "Alkaline Extract ", 
containing DPI'H and TPNH, plus small amounts of DPN and 
TPN, was mixed with 0.15 ml N. HC1, kept for 5 minutes at 
60 °, cooled and pH adjusted to 8.2. The resultant solution 
containing small amounts of DPN and TPN was then treated 
with G6PDH and G6P as described in the previous paragraph. 
The product (Solution B) now contains DPN and TPEH. 
A second 2 ml volume of "Alkaline Extract" was 
mixed with 0.15 ml N -NaOH, kept for 15 minutes at 60 °, 
cooled and adjusted to pH 8.2. The resultant solution, 
containing DPNH & TPNli,was mixed with 0.05 ml 0.03 M 
ethylenediaminetetra- acetate (EDTA), 0.01 ml alcohol 
dehydrogenase and 0.04 ml 0.0075 M acetaldehyde and kept 
at room temperature for 20 minutes. The product (Solution 
C) now contains DPN and TPNH 
In subsequent stages of the analysis Solutions 
A, B and C were treated similarly. Eight 0.25 ml volumes 
of each solution were measured into tubes for use in the 
Farrand.Pluorimeter - Model A (Farrand Optical Co. Inc., 
New York). To one pair of tubes (a) was added 0.05 ml 
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water, to a second (b) 0.02 ml N. HC1 + 0.03 ml water, to 
a third (c) 0.02 ml N. HC1 followed after 5 minutes by 0.07 
ml N -NaOH and to a fourth (d) 0.05 ml N.NaOH. The contents 
of all tubes were mixed and tubes (c) and (d) containing 
added alkali were heated at 60° for 15 minutes and cooled. 
A 0.21 ml volume of the NaOH -H202 solution was added to all 
tubes. After mixing the tubes were incubated for 1 hr. at 
38° and the contents finally diluted with 2 ml water. The 
fluorescence developed was measured in the fluorimeter with 
primary filterFarrandNo. 5860 and secondary filters Farran 
No.3389 and 4308 and Wratten No. 2B. The instrument was 
standardised against a solution of 0.005 µg /ml quinine 
sulphate in 0.1 N H2SO4 each time before use. 
Range of the proportionality of the amount of coenzyme and 
degree of fluorescence 
As shown in Fig. III. 1 the relationship between 
the fluorimeter galvanometer readings and the concentrations 
of pyridine nucleotides in the solution is linear up to a 
concentration of 1 mµmole per tube, above which the curve 
starts to flatten out. The amount of the uterine extract 
taken for a determination was therefore selected to ensure 
that this concentration was not exceeded. 
0.5 1.0 1.5 
DPN Cm» mole /tube) 
2.0 
Fig. III. 1. Relationship between amounts of DPN and degree 
of fluorescence developed. 
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Recovery of added coenzymes 
The recovery of DPI, DPNH, TPF and TPNH was 
determined after adding known amounts of these substances 
to the hot extracting media alone and to the hot media 
during extractions of uterine tissue. The native coenzymes 
were determined separately. The results are shown in Table 
III. 1. In the author's hands, the method gives slightly 
lower recovery of the nucleotides than was reported by 
Bassham et al (1959), who worked with liver. However, 
here much lower concentrations of pyridine nucleotides of 
the rat uterus (as compared with the high coenzyme 
concentrations of the rat liver) were under consideration. 
As seen in Table III. 1 high recovery of coenzyme was 
obtained when only extracting media were used as compared 
with that when uterine tissue was present. This may be 
due to the presence of substances which tend to quench the 
fluorescence of nucleotides slightly. Hems (personal 
communication) also experienced this quenching effect in 
the liver extracts. It is only logical that, the lower 
the concentration of nucleotides in the solution (as in 
the case of the uterus) the more marked is the quenching 
effect. 
Table III. 1. 
Recovery of pyridine nucleotides added to either extracting medium 
alone, or to uterine preparation during extract w ,Values are means 
with Standard Error of Means (S.E.M.). Numbers in parentheses 
indicate numbers of experiments. 
Coenzymes 
mµ mole of coenzyme 





( %) ( %) 
DPN 20 - 30 104 (1) 90 ± 6.8 (9) 
TPN 3 - 14 90 (1) 76 + 6.0 (9) 
DPNH 10 - 30 84 + 2.0 (7) 8o + 12.7 (5) 
TPNH 10 - 25 88 + 2.7 (7) 76 ± 13.1 (5) 
- 60 
RESULTS 
The concentrations of oxidised and reduced 
pyridine nucleotides were determined in the uteri from 
ovariectomised rats untreated and after administration of 
oestradiol either subcutaneously or intravenously. Uteri 
from intact 'normal' animals, (killed at randorastages of 
the oestrous cycle) were also analysed for comparison. 
Results summarised in Table III. 2 and Fig. III. 2 show 
concentrations of pyridine nucleotides in the rat uteri 
expressed per unit wet and dry weight respectively. There 
is no apparent marked difference between results expressed 
in either of these ways, although there is some difference 
in the water content of the uteri in the different groups 
of animals (see Table III. 3). In general, DPN and TPh 
concentrations in uteri of 'castrate rats are not significantly 
different from those in oestrogen -treated animals nor from 
those of 'normal' rats. The concentrations of oxidised 
coenzymes seem to fluctuate, without any recognisable 
pattern, within the limits of experimental error. On the 
contrary, changes in the reduced pyridine coenzymes follow 
a definite pattern. Thus both uterine DPNH and TPNH 
concentrations in the castrate rats decrease 6 hours after 
oestrogen administration, but start to rise again by the 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table III. 3. 
Percentages dry weight of uteri (with S.E.M.) from rats of different 
oestrogenic status. 
Types of rats dry weight Yo. of 
experiments 
' Iiormal' 18.0 + 0.65 4 
* 
OVX 21.5 ± 0.36 10 
OVX, 6 hrs. after OD * *(i.v.) injection 16.1 + 0.62 4 
OVX, 24 hrs. after OD (i.v.) injection 18.6 ± 0.38 3 
OVX, 72 hrs. after OD (s.c.) injection 18.6 + 0.52 3 
* 
OVX = ovariectomised 
** 
OD = oestradiol 
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administration of oestrogen. Furthermore, when oestradiol 
was administered daily to ovariectomised rats for 3 days, 
DPNH concentration at the 72nd hour from the first oestrogen 
injection is very markedly higher than the concentration in 
the untreated ovariectomised animals. There is only a 
slight increase in TPNH concentration at a similar time. 
Both DPNH and TPNH levels in the 'normal' rats are also 
higher than the ovariectomised rat values. (Only the decrease, 
of DPNH concentration after 6 hours ,. and the increase of 
DPNH concentrations after 72 hours of oestrogen treatment 
are significantly different from the values in the untreated 
ovariectomised rats). 
Since the oxidised coenzyme levels are almost 
constant, the increase and decrease in the DPN /DPTH and 
TPN /TPNB ratios depend largely on the concentration of 
reduced coenzymes. Thus the DPP /DPN?H and TPN /TPNH ratios 
appear to increase slightly up to 36 hours from the time 
of oestradiol administration as compared with the untreated 
ovariectomised animals. Both coenzyme ratios are markedly 
lowered in the animals receiving oestrogen daily over three 
days and killed on the fourth. The two ratios are also 
lower in the 'normal' rats than in the spayed rats (Table 
III. 2). 
The uterine weight dropped markedly after 
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ovariectomy (Table III. 4), and increased gradually as a 
result of growth following oestradiol administration. When 
the quantities of the di- and triphosphopyridine nucleotides 
in the rat uterus are expressed as mµ moles per gland, as 
in Table III. 4 it is seen that they decrease sharply as an 
effect of ovariectomy and increase gradually towards the 
'normal' rat values following oestrogen administration. 
Both uterine weight and pyridine nucleotide concentration 
show increases of the same order following administration 
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DISCUSSION 
The relative amounts of DPN, DPNH, TPN and 
TPNH in the rat uterus are found to be similar to those 
in other tissues (see Clock & McLean, 1955b). Thus 
diphosphopyridine nucleotide, mostly in the oxidised form, 
is in much greater concentration than triphosphopyridine 
nucleotide, the majority of which is in the reduced form. 
The concentrations of the coenzymes in the 
rat uterus are however in general much lower than in the 
liver or adrenal gland but are within the ranges of many 
other tissues (see Clock & McLean, 1955b). The low 
concentrations of the coenzymes, however, do not reflect 
inactivity of the tissue since the concentrations in the 
proliferating uterus are not much greater than those in the 
atrophic gland. It would appear that relatively low 
concentrations of coenzyme suffice for the 'normal' range 
of metabolic activities in this tissue. Perhaps this is 
not unusual. In some in vitro systems such as the 
oestrogen -activated transhydrogenase system only a minute 
catalytic amount of TPN (5 X 10 $M) is necessary and higher 
concentrations such as 10-5M are inhibitive (Talalay et al, 
1958). 
Ovariectomy and subsequent oestrogen treatment 
have little effect on the concentrations of oxidised 
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coenzymes in the uterus, but the effect on the concentrations 
of reduced coenzymes are more pronounced, especially in the 
case of DPNH. The DPNH concentration, 72 hours after 
oestrogen administration, is significantly higher than the 
castrate rat levels and the trend of the change in TPNH 
concentration is similar. These data suggest that an 
ultimate action of oestrogen in vivo is to lower the DPN /DPNH 
and TPN /TPNH ratios. 
The fact that both of these ratios change in 
the same direction diminishes the likelihood that 
transhydrogenation is involved as a result of oestrogen 
action in the tissue (see p.46 ). This would be in keeping 
with the report in SECTION II that no significant 
transhydrogenase activity could be detected in the rat uterus 
in the absence or presence of oestrogen. However, the 
increased concentrations of DPNH and TPNH, no matter how 
brought about, may reflect the demand for energy (from the 
former) and specific reductant (from the latter) for 
biosynthesis occurring in response to oestrogen. 
The marked decreases in DPNH and TPNH levels, 
6 hours after oestrogen treatment, and their increases 
thereafter reaching highest values by the 72nd hour, may 
indicate changes in the rate at which the two reduced 
coenzymes are produced and utilised. An increased rate of 
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re- oxidation of DPNH and TPNH coupled with a lesser or non- 
increased rate of production of the two reduced coenzymes 
would result in the lowering of their concentrations in the 
uteri (e.g. 6 hour levels). Similarly, on the other hand, 
a much greater acceleration of the rate of production of 
reduced coenzymes,without a corresponding increase in the 
;rate of their utilisation, would result in an increase in 
DPNH and TPNH concentrations (e.g. 72 hour levels). There 
is evidence in support of this theory. Thus rapid water 
imbibition in the rat uterus is known to occur following 
oestrogen administration. This attains a maximum between 
4 and 6 hours after giving oestrogen (Ashwood, 1938; see 
also Table III. 3). During this period, oxygen consumption 
and glucose utilisation also increase (Szego & Roberts) 
1953). These observations suggest that between 4 and 6 
hours after oestrogen injection, much energy is being 
consumed, such as in transportation of water into uterine 
tissue and possibly also in biosynthetic processes, especially 
those of ribonucleic acid and protein which are accelerated 
at this stage (Mueller et al, 1958). These processes would 
involve an increase in the oxidation of DPNH and TP1'H 
(see p. 7 ). The uterine levels of some DPN- and TPN- linked 
dehydrogenases are found to be unchanged at this early stage 
of oestrogen treatment (Mongkolkul & Grant, 1960; see also 
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SECTION IV, Fig. IV. 1). Assuming these pyridine 
nucleotide reducing enzymes are rate limiting and cannot 
keep up with the increased reoxidation processes discussed 
above, it is possible to imagine a decrease in DPI+H and 
TPNH levels 6 hours after oestrogen treatment. On the 
other hand, levels of some DPN- and TPN dependent 
dehydrogenases are found to be increasing by 3 to 4 fold 
72 hours after giving oestrogen (Bever et al, 1956; 
Liongkolkul & Grant, 1960; see also SECTION IV, Fig. IV. 1) 
while there is no evidence of any further increased rate of 
reoxidation of DPEH and TPNH. Moreover, "DPN?H- oxidase" 
activity is reported to be rate limiting in the lactic acid 
dehydrogenase- "DPNH- oxidase" system (Bever et al, 1956). 
The rate of production of reduced coenzymes thus appears 
to be greater than their reoxidation rate, and an accumulation 
of the reduced coenzymes may be expected. It must be pointed 
out that the TPNH level, already higher than TPN in the 
uterine tissue (Table III. 2), is not likely to be increased 
drastically under the circumstances. DPNH level, however, 
may be raised substantially in view of the fact that this 
coenzyme exists mainly in the oxidised form (Table III. 2). 
These reasonings are well in accord with data obtained in 
the present investigation. 
Although there is no dramatic change in the 
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concentrations of the pyridine nucleotides per unit weight 
of rat uterus following oestrogen administration, the 
absolute amount of the nucleotides per uterus does in fact 
increase, mainly by virtue of the increased weight of the 
organ. The rise in the amount of these pyridine 
nucleotides is probably accompanying the general uterine 
growth induced by the oestrogen administration. The rates 
of biosyntheses of pyridine nucleotides and nucleic acids 
are likely to depend on the rate of synthesis of adenine, 
one of the main components of these substances. The 
rates of incorporation of labelled substrates into adenine 
(and guanine) in the rat uterus is know to be increased 
very early after oestrogen administration (Mueller et al, 
1958). However, the increases in the rates of biosyntheses 
of these bases do not promote the in vivo syntheses of_ 
pyridine nucleotides and the two types of nucleic acids 
(ribose nucleic acid, RNA1and deoxyribose nucleic acid, 
DI1A) at the same time. Thus the amount (mg /uterus) of 
RNA increases between 6 and 21 hours after oestrogen injection 
and that of DNA increases between 48 and 72 hours (Telfer, 
1953). The increases in pyridine nucleotides, found in 
this investigation to parallel roughly uterine growth, 
probably start about 24 hours after oestrogen treatment, 
the period at which true growth begins (Mueller et al, 1958). 
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It is interesting that the sequences of the biosynthesis of 
RNA, DNA and pyridine nucleotides in the uterus, after 
oestrogen treatment agree well with observations on other 
aspects of uterine growth. Thus the early accumulation of 
REA is probably necessary for an increase in protein 
biosynthesis, which also starts at an early stage after 
oestrogen treatment (Mueller et al, 1958); pyridine 
nucleotides appear to be formed at about the same time as 
other extra nuclear cell constituents. Finally, DNA does 
not accumulate until uterine cells are ready to divide. 
Enhancement of the biosyntheses of nucleotides 
and nucleic acid required an increase in the supply of 
pentose phosphate. Glock (1955) and Glock & McLean (1958) 
suggest that in many tissues the pentose phosphate may come 
mainly from the hexosemonophosphate 'shunt' pathway of 
glucose oxidation. The evidence that there is an increase 
in the levels of 'shunt' enzymes in the rat uterus after 
oestrogen treatment will be found in SECTION IV of this 
thesis. 
SECTION IV 
EFFECTS OF OESTROGENS ON THE LEVELS OF PYRIDINE 
NUCLEOTIDE -LINKED DEHYDROGENASES IN THE RAT 
UTERUS. 
- oÿ - 
INTRODUCTION 
In attempts to understand how hormones work 
in the body, many investigators have studied their effects 
on the levels of enzymes in various tissues. (Since it is 
possible that the hormones may influence the amount or the 
activity of a given enzyme or perhaps both, the term 
'level' has been adopted and taken to cover any way in 
which the enzyme may be influenced by the hormone). It 
has been hoped that changes in the levels of certain enzymes, 
which may occur after the administration of a hormone, may 
bear some relationship to the physiological activity of the 
hormone, and thus throw some light on its mechanism of 
action. A list showing how some hormones, including 
oestrogens, affect the levels of many enzymes in animal 
tissues is given in the General Introduction (p.10). The 
finding that DPNH and TPNH concentrations in the 
ovariectomised rat uteri increase 3 days after oestradiol 
administration (see SECTION III) prompted the study, about 
to be reported, of the effects of oestrogens on DPN and 
TPN- dependent dehydrogenases in the rat uteri. 
The three principal oestrogens found in man, 
oestradiol, oestrone and oestriol, are not known to be the 
natural oestrogens of the rat. Nevertheless they influence 
certain rat tissues in a manner similar to that found in man. 
- 7U- 
It may therefore be justifiable to compare their action on 
enzymes in the rat. It must also be borne in mind that the 
activity of these substances varies considerably with methods 
and techniques employed (see Merrill, 1958). It is thus 
interesting to study the relative activities of these three 
oestrogenic substances on the uterine levels of dehydrogenases 
to be investigated. 
In an attempt to find whether any increases in 
dehydrogenase levels observed are due to increased enzyme 
activity or to synthesis of new enzyme protein, the effect 
of substances influencing protein synthesis or growth 
processes in general was studied. Progesterone, testosterone 
and DOC acetate when administered individually to 
ovariectomised rats in mg. quantities are reported to promote 
some uterine growth, but when each of these substances is 
administered with oestradiol to similar animals there are 
marked decreases in uterine growth as compared with the 
effect of oestradiol alone (Velardo,1959). ICIER -25 l(p -2- 
diethlaminoethoxyphenyl) -1- phenyl -2 -p- methoxyphenyl ethanol 
(see formula, p.18 ) has been shown to decrease the growth 
response to oestrogen in uteri of mice (Lerner et al, 1958). 
DON or 6- diazo- 5- oxo -L- norleucine (formula shown on p. 71) 
has been shown to inhibit vaginal and uterine growth in mice 
given oestradiol (Paulson, 1960). Being similar in structure 
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to glutamine, DON is known to compete with this compound in 
the synthesis of protein and of purines or RYA (see Buchanan, 
1958), and RNA synthesis is now known to occur hand in hand 
with protein synthesis (see Zamecnik, 1958). DON probably 
inhibits uterine growth, induced by the administration of 
oestrogen, by interfering with protein synthesis directly 
and indirectly. The mechanism by which progesterone, 
testosterone, DOC acetate and ER -25 antagonise oestrogen 
effect is, however, not yet clear. The effect of in vivo 
administration, individually or together with oestradiol, 
of these steroids and oestrogen antagonists on the levels 
of uterine dehydrogenases has now been investigated. 
Lastly, the effect of thyroxine on the levels 
of uterine dehydrogenases was studied. The thyroid hormone 
has been reported to increase rat liver levels of G6PDH and 
6PGDH (Glock et al, 1956; Huggins & Yao, 1959), and it is 
of interest to know if it has any effect on similar enzymes 
in the uterus. 
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PLAN OF INV,STIGATIONS 
In the experiments to be described in this 
Section, the levels of four pyridine nucleotide -linked 
dehydrogenases in the uterus of the rat were measured before 
and after modification of oestrogenic status of the animal. 
Injéction of oestradiol was usually employed for this purpose 
but a comparative study of the effect of oestradiol, oestrone 
and oestriol on the rat uterine dehydrogenases was also made. 
The enzymes concerned are glucose -6- phosphate (G6PDH), 
6- phosphogluconate (6PGDH), isocitric (ICDH), and lactic 
(LDH) dehydrogenases, located in the 'soluble' part of the 
cell sap. Bever et al (1956) have reported that LDH 
activity increases following oestrogen administration to 
ovariectomised animals. It was decided, however, to 
reinvestigate this effect using a simpler and more direct 
technique, in order to obtain results for comparison with 
data to be obtained on the study of TPN- dependent 
dehydrogenases. 
The effects of in vivo administration of 
thyroxine and of antagonists of oestrogen action or of growth 
inhibitors referred to in the Introduction were also 
investigated. 
A preliminary report of this work was presented 
-74- 
to the Biochemical Society (Mongkolkul & Grant, 1960). 
-75- J 
EXPERIMENTAL 
The Animals and Operations were similar to 
those described in SECTION III (p. 50). 
Injections 
The steroids for subcutaneous (s.c.) injection 
were dissolved in a minimum amount of ethanol and diluted 
with sesame or olive oil to the required concentrations. 
For intravenous injections, solutions of oestradiol in 
physiological saline were prepared by the method of Roberts 
& Szego (1947). Volumes of 0.1 ml were injected. 
Progesterone (1 mg), testosterone (1 mg) and DOC acetate 
(3 mg) were injected (s.c.) daily for three days. Unless 
otherwise stated, throughout this section, dosage refers to 
the amount administered each day. Injections (s. c.) were 
carried out on three consecutive mornings. The animals 
were killed 24 hours after the last injection. 
A volume of 0.2 ml of a solution of 1 mg DON/ml 
physiological saline was injected five times intraperitoneally 
on the mornings and late afternoons of two consecutive days. 
The fifth injection was made on the morning of the third day. 
When oestradiol was to be given along' with DON, 0.1 ml 
solution, containing 0.4 µg of the steroid, were injected 
subcutaneously four times, coinciding with the first four 
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injections of DON. This is a slight modification of the 
Paulson (1960) procedure. 
The method of Lerner et al (1958) for the 
administration of LER -25 was followed with some modification. 
A suspension (17 mg /ml) of the compound in olive oil was 
made. Volumes of 0.1 ml were injected subcutaneously twice 
daily for 3 days. 
In some experiments animals received a daily 
subcutaneous injection of 0.5 mg DL- thyroxine for 8 days as 
described by Glock & McLean (1955c). When oestradiol was 
given simultaneously, it was administered with the last 3 
thyroxine injections. 
Preparation of the uterine tissue and dry weight determination 
This was done as described under Methods in 
SECTION III (p. 50). 
Preparation of Enzymes 
Pieces of uterine tissue, free from adhering 
fat and connective tissue and weighing about 100 mg, were 
homogenised for two minutes in a cone -shaped ground glass 
homogeniser containing about 10 ml of ice -cold solution of 
0.15 M KC1. The volumes were measured and the homo_;enates 
centrifuged at 11,000 g. for 15 min. in an M.S.E. refrigerated 
-77- 
centrifuge. The supernatant solutions were not usually 
dialysed as described by Glock & McLean (1953) since this 
caused considerable loss in activity, and assays of enzymes 
were carried out on them without delay. However, when 
dialysis was employed, the extract was put in a cellophane 
sac and dialysed for 4 hours at 00 C against excess 0.15 M 
KC1 solution. The KC1 solution was changed after 2 hours. 
A magnetic stirrer was used to make the dialysis more 
efficient. 
Determination of protein in the enzyme 
preparations was carried out by the Biuret method as follows. 
One ml of the uterine extract was mixed with 2 ml of 4 l- 
NaOH solution and 0.25 ml of a l; solution of CuSO4.5H2O, 
and the absorbance at 540 mµ was measured at exactly the 
20th minute after the mixing. A standard solution of 
1 mg /ml bovine serum albumin (Armour & Co.) was used with 
each determination. The amount of protein found in the 
extracts was approximately 1 mg /ml. 
Enzyme assays and units 
Spectrophotometric determinations were made with 
the Unlearn SP500 spectrophotometer at room temperature 
(about 20 °), using silica cuvettes of 1 cm. light path. 
The reduction or oxidation of pyridine nucleotides was 
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followed by measurement of change in optical density at 
340 nap. Only the initial velocity of the reaction was used 
in calculating enzyme activity. The molar extinction 
coefficient of reduced coenzymes was taken as 6,220. A 
unit of dehydrogenase activity is defined as that which 
either reduces or oxidises 1 µmole of the pyridine nucleotide 
per minute, and results are expressed as units per g. dry 
uterine weight. Similar values are obtained when results 
are expressed as enzyme units per mg. rrotein in the 
preparation. 
The assay of G6PDH is a modification of the 
double substrate method of Glock & McLean (1953). The 
reaction mixture consists of 83 mM tris buffer pH 7.4; 17 mM 
L2,C12; 0.17 mhi TPN; 1.7 mM disodium- 6- phosphogluconate; 
3.3 miv disodium glucose -6- phosphate and 0.01 -0.02 ml enzyme 
preparation, in a final volume of 0.3 ml. Micro- couvettes 
were used. Blanks are prepared without substrate. 
The assay of 6PGDH is also based on that of 
Glock & McLean (1953). The reaction mixture contains 
exactly the same components as for the assay of G6PDH 
described above, except that G62 was omitted. 
The assay of ICDH is carried out using the 
following reaction mixture: 83 mM tris buffer, pH 7.4; 
3.3 mÌú MnC12; 2 1111.1 DL- isocitrate, 0.17 mM TPN and 0.2 ml 
-79- 
of the uterine extract in a final volume of 3.0 ml. The 
blank couvette contains no TPN. 
The assay of LDH is adapted from the method of 
Kubowitz & Ott (1943). The reaction mixture consists of 
83 mM tris buffer, pH 7.4; 0.1 mM DP1H; 3 mM sodium 
pyruvate; and 0.05 ml of the enzyme preparation, in a final 
volume of 3.0 ml. The blank couvette contains no D?PHi. 
Reliability of methods 
Four separate determinations of the dehydrogenase 
activities on a single uterus from an intact ('normal') rat 
were carried out. Results summarised in Table IV. 1 show 
that agreement within 10% SEM is obtained. 
Table IV. 1. 
Results from 4 separate determinations of dehydrogenase 
activities in a single rat uterus. Enzymic activities 
are expressed as means 4- S.E.M. 
Enzymes Activities 
(units /g dry weight) 





18.3 ± 1.95 
6.7 + 0.27 
12.5 ± 0.33 
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RLSULTS 
(i) Effect, on uterine dry weight and 
dehydrogenase levels, of prolonged oestrogen administration 
to ovariectomised rats. 
Results summarised in Table IV. 2 show the dry 
weights and levels of G6PDH, 6PGDH, ICDH and LDH in uteri 
from 'normal' (see definition, p.48 ), untreated 
ovariectomised, and ovariectomised rats injected 
subcutaneously with a daily dose of 10 pg of oestradiol for 
periods up to 24 days. The same results are shown in a 
diagrammatic form in Fig. IV. 1. The castrate rat levels 
of G6PDH and 6PGDH are only 37 and 34% of 'normal' rat 
values respectively. However, when oestradiol is 
administered to the ovariectomised animals, the levels of 
both enzymes increase markedly and steadily, reaching the 
'normal' rat values by the 2nd day and maximum levels are 
attained on the 4th day after the start of oestrogen 
injections. The values of G6PDH and 6PGDH levels on the 
4th day are 8 and 6 times those cf castrate rat levels 
respectively. After attaining a maximum the levels of 
both enzymes are seen to decrease by the 5th and the 6th 
days, after which they are almost constant up to the 15th 
day. By the 24th day, however, the levels are slightly 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































FIG . (1V.4) A TIME -COURSE STUDY ON THE EFFECT OF 
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Note. For details, Fig. IV. 1 should be compared with Table IV. 2 (p BO). 
Vertical bars represent S.E.M. When no vertical bars are shown, S.E.M. 
are too small to be included in the diagram. Lines above and below 
striped areas labelled "'normal' rat level" represent means + S.E.M. and 
means - S.E.M. respectively. 
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peak of 6PGDH activity on the 9th day is not at present 
apparent. It may be noted that G6PDH level is always about 
3 times higher than that of 6PGDH. 
A different picture is obtained when the enzyme 
ICDH is considered. The level of this enzyme in the castrate 
animal is only slightly (15%) lower than in 'normal' rats. 
There is some insignificant fluctuation of this enzyme level 
after oestradiol administration. As a whole, the ICDH 
level remains slightly below the 'normal' rat value up to 
24 days of the oestrogen treatment. 
LDH level in the castrate rat uteri is only 
57 of 'normal' rat value. After oestradiol administration, 
this enzyme level increases markedly, overtaking 'normal' 
rat level on the 2nd day and reaching maximum level on the 
3rd day. This maximum level, about 4 times that of the 
castrate rat value, is retained with a slight tendency to 
decrease towards 'normal' rat on the 15th and 24th days 
after oestrogen treatment. It may be noted that LDH level 
is the highest of the enzymes investigated. 
The uterine dry weight of the castrate rat is 
only 25% of 'normal' rat (Table IV. 2). The weight, 
however, increases gradually following the oestrogen 
administration returning to 'normal' rat level on the 4th 
day. This level is retained up to 24th day of the oestrogen 
- 82 - 
treatment. Because of this 4 fold increase in the uterine 
dry weight on the 4th day after oestrogen. treatment, G6PDH, 
6PGDH, ICDH and LDH levels at this time, expressed per uterus, 
are respectively 32, 24, 4 and 16 times the levels observed 
in the castrate rat uterus. 
It is noted that the dry weight and levels of 
G6PDH, 6PGDH, ICDH and LDH are not significantly changed 
4 hours after intravenous oestradiol administration to 
castrate rats (Table IV. 2). The changes in the dry weight 
and dehydrogenase levels in castrate rats 24 hours after 
intravenous injection of oestradiol are very similar to 
changes obtained after the same amount of the oestrogen is 
administered subcutaneously to these animals. 
When mean values of dry weight and dehydrogenase 
levels per uterus of castrate rats, with and without oestrogen 
treatment, are expressed as percentages of similar values of 
'normal' rats (Fig. IV. 2), it is possible to see how 
deviations from 'normal' occur following the stated treatment. 
Again the castrate rat uterine dry weight decreases to a 
quarter of the 'normal' value but increases steadily following 
oestradiol injections and reaches the 'normal' value about 
the 4th day. This 'normal' dry weight value is retained 
as long as oestrogen administration is continued. The 75% 

































































































































































































































































































































gradual increase when oestradiol is subsequently injected, 
are closely similar to the changes in the dry weight. On 
the other hand, G6PDH, 6PGDH, LDH levels are more labile 
under the same circumstances. After ovariectomy they 
decrease to about 10% of 'normal' value, but start to increase 
sharply after oestrogen administration. The levels 4 days 
after oestradiol treatment are 200 -25O of 'normal' values. 
The high level of the three dehydrogenases are retained, with 
some fluctuations, up to 9 days after the start of the 
treatment, but appear to decrease towards 'normal' values 
by the 15th and 24th days. 
Effect of dosages of oestradiol: 
Changes in the uterine dehydrogenase levels on 
subcutaneous administration of oestradiol to ovariectomised 
rats are influenced by the dosages of injected hormone. 
Fig. IV. 3 shows that the activities of G6PDH and 6PGDH 
increase linearly with doses of from 0.1 to 1.0 µg oestradiol, 
after which higher doses even up to 10 µg of the hormone 
promote only slight and insignificant increases in the enzyme 
activities. As little as 0.5 µg oestradiol appears to be 
enough to promote maximal response to the activity of LDH. 


















O 02 04 06 O$ fO 10.0 
A. OF OESTRADIOL ( DAILY FOR 3 DAYS) 
Fig. IV. 3. The relationship between uterine dehydrogenase 
activities and daily doses of oestradiol injected 
subcutaneously to castrate rats for three days. Numbers 
shown in parentheses indicate the number of experiments 
done at each oestrogen level. The vertical lines represent 
S.E.M. 
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Effect of different oestrogenic steroids: 
Oestradiol, oestrone and oestriol appear to 
affect rat uterine levels of G6PDH, 6PGDH, ICDH and LDH in 
similar manner (Table IV. 3). However, the order of 
effectiveness in promoting changes in these dehydrogenases, 
especially of LDH, appears in general to be oestriol, oestrone 
and oestradiol, respectively. 
(ii) Effect on the uterine dehydrogenases of 
oestrogen antagonists and thyroxine administered alone and 
together with oestradiol. 
Results summarised in Table IV. 4 show that 
progesterone, testosterone and DOC acetate, when administered 
individually to the castrate rats, promote some uterine 
growth, accompanied by slight increases in the levels of 
G6PDH, 6PGDH and LDH. Progesterone and testosterone appear 
to be equally effective in promoting uterine growth, and 
DOC acetate the least effective of the three. When 
administered together with oestradiol, progesterone markedly 
inhibits the effects of oestradiol on the levels of the 
enzymes studied, especially those of G6PDH and LDH. 
Testosterone and DOC acetate also inhibit the oestradiol 
effect, but to a lesser extent. 
Table IV. 4 also shows that either IER -25 or 
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levels of G6PDH, 6PGDH and LDH. However, when either 
compound is injected along with oestradiol, there are 
pronounced decreases in the uterine weight and dehydrogenases 
levels. 
Thyroxine administered to castrate rats has no 
effect on the uterine levels of G6PDH, 6PGDH and LDH. 
Lioreover, the thyroid hormone administered together with 
oestradiol, shows neither synergistic nor antagonistic effects 
as far as the levels of the three dehydrogenases in the rat 
uterus are concerned. 
- 86 - 
DISCUSSION 
As predicted in SECTION III, there are marked 
increases in levels of DPI? and TPN- dependent dehydrogenases 
in the uteri of ovariectomised rats treated with oestrogen. 
However, not every enzyme shows this upward response. Thus 
G6PDH and 6PGDH show an increase but the level of ICDH is 
uninfluenced. The effects observed on G62DH and 62GDH are 
in agreement with the report of Scott & Lisi (1960) who find 
a 3 fold increase in the levels of these enzymes in the 
endometrium and 2 fold increase in the myometrium of the 
ovariectomised rat uteri, 36 hours after an intraperitoneal 
injection of 100 µg oestradiol. Both enzyme levels are 
reported by the same authors to fall significantly by the 
76th hour, presumably due to the destruction in the rat 
body of the administered oestrogen. It is seen, however, 
from the results of the present investigation (Fig. IV. 1) 
that repeated administrations of smaller dosages of the 
oestrogen (10 pg per day) produce much higher increases in 
the levels of the two enzymes by the 4th day after the first 
injection. It may be noted that the degree of enzymic 
response is dependent on the amount of oestrogen administered. 
A minimum dosage of 0.1 µg per day appears to be necessary 
to produce a significant increase in the dehydrogenase 
levels, and 1 pg per day is the dosage above which no 
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further significant increase is obtained (Fig. IV. 3). The 
method of oestrogen administration does not appear to have 
any influence on the enzymic levels, as judged from 
observations made up to 24 hours after a single subcutaneous, 
intravenous or intraperitoneal injection of oestrogen (Table 
IV. 2 and data from Scott & Lisi, 1960). 
The observation of Bever et al (1956) that 
oestriol is more active than oestradiol or oestrone in 
increasing the LDH level in the rat uterus, has been confirmed 
and the same observation has now been made for G6PDH (Table 
IV. 3) but is not found with 6PGDH. 
Huggins & Yaa (1959) report that the levels of 
6PGDH in the liver increase 2 fold, 10-13 days after 
oestradiol treatment but the G6PDH level does not change in 
the same period. This observation was confirmed by the 
author in the preliminary experiments, but there is no sign 
of a similar phenomenon with uterine 6PGDH or G6PDH when 
animals were subjected to the same oestrogen treatment for 
up to 24 days. This finding may be cited as an example of 
a hormone having different effects on different tissues. 
Another similar example is that of thyroxine which increases 
both the G6PDH and 6PGDH levels in the liver (Glock et al, 
1956; Huggins & Yet), 1959) but is without any effect on the 
uterine enzymes (Table IV. 4). 
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One outstanding effect of oestrogen 
administration to the ovariectomised rat is its 'normalising' 
on the uterus, i.e. the tendency to restore conditions (e.g. 
dryweight and enzymic activities) to their pre -ovariectomy 
values. There are however considerable differences in the 
ways in which the different enzymes approach the 'normal' 
values. The increase of ICDH level after oestradiol 
treatment is slow, and parallel to the rise in the uterine 
dryweight. Both reach the 'normal' levels 4 days after the 
start of oestrogen administration (Fig. IV. 2), and both 
ICDH level and uterine dryweight remain 'normal' if the 
administration of oestrogen is continued. This suggests 
that the increase in ICDH level may be due to synthesis of 
specific protein having ICDH activity at about the same pace 
as general growth. On the other hand, the levels of G6PDH, 
6PGDH and LDH rise more abruptly and more extensively after 
the oestrogen administration, and pass 'normal' levels 2 
days after oestrogen is first administered. The maximum 
values attained are 2 -3 times those found in 'normal' rats. 
These high levels are maintained for a period of up to 9 
days before finally decreasing towards 'normal' values even 
with continued daily injections of oestradiol. It thus 
appears possible that the specific proteins having these 
three dehydrogenase activities are being synthesised at a 
- 89 - 
much faster rate than the general growth. However, the 
ultimate results are the same as before, viz. that 'normal' 
values are attained and maintained as long as the supply 
of oestrogen is continued. 
Judging from the results obtained, there appears 
to be a close relationship between the increases in the 
levels of uterine dehydrogenases studied and the uterine 
growth, as measured by the increase in the uterine dryweight. 
The highest levels of G6PDH, 6PGDH and LDH are obtained when 
growth is also at its maximum, i.e. 4 days after oestrogen 
treatment commences. There is only a small increase in the 
weight of uteri from castrate rats when they are killed, 
either (a) 1 day after a single injection of 10 µg oestradiol, 
(b) 3 days after daily injections of 0.1 µg oestradiol or 
(c) 3 days after daily injection of 1 mg of progesterone, 
testosterone or DOC acetate. Under such conditions the 
increases in the levels of the three dehydrogenases are also 
slight. Furthermore, when the uterine growth is restricted 
by the administration, together with oestradiol, of substances 
inhibiting growth or protein synthesis, viz. MER -25, DON, 
and progesterone, testosterone and DOC acetate, there are 
correspondingly decreased effects of oestradiol on the levels 
of enzymes studied. It may be noted that these substances 
which are potent oestrogen antagonists, such as IER -25, DON 
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or progesterone, are more successful in this respect than 
weak antagonists like testosterone or DOC acetate. It is 
also interesting that thyroxine, which neither promotes nor 
inhibits uterine growth induced by oestrogen, has no effect 
on levels of enzymes investigated. The fact that increases 
in enzymic levels and uterine growth always occur together 
appears to support the theory that the increases observed 
after oestrogen treatment are a result of formation of new 
enzyme protein_, rather than a direct oestrogen stimulation 
of existing enzyme molecules. The view that oestrogen does 
not directly activate dehydrogenase molecules is strengthened 
by the failure to demonstrate an increase in the activity of 
the enzymes under consideration, by oestradiol added in 
vitro (Bever, 1958; Scott & Lisi, 1960). 
The physiological significance of the increases 
in dehydrogenase concentrations observed after oestrogen 
administration is difficult to assess. It is only 
reasonable to suppose that enzymes, the levels of which do 
not change markedly on ovariectomy and subsequent oestrogen 
administration, are those primarily concerned with normal 
day to day metabolism, and are not specifically involved 
in growth processes induced by oestrogen administration. 
ICDH belongs to this group of enzymes. On the other hand, 
other uterine enzymes such as G6PDH, 6PGDH and LDI -I, whose 
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concentrations fall and rise extensively according to the 
oestrogenic status of the animals, are also likely to take 
part in the processes which bring about the characteristic 
uterine growth in response to oestrogen. The possible 
significance of the LDH -DPNH- oxidase system in controlling 
the reversible oxidation and reduction of lactate and 
pyruvate at the end of glycolytic sequence of reactions has 
alre..dy been mentioned by Bever (1958). As far as growth 
is concerned, LDH could provide DPIH which can then be 
oxidised via the cytochrome system giving ATP, i.e. increasing 
the free energy supply for endergonic biosynthetic processes. 
This view is supported by the fact that the DPIVH concentration 
in rat uteri 3 days after oestrogen treatment (when level of 
LDH is at its highest) is also found to be markedly increased 
(see SECTION III, p. 61). Another aspect of the elevated 
LDH level which may be of physiological importance is its 
possible role as a promoter of transhydrogenation. LDH, 
which can react with either DPN or TPN, is known to mediate 
in the transfer of hydrogen (Navazio, Ernster & Ernster, 
1957; Holzer & Schneider, 1958) according to the following 
scheme:- 
'TPN lactate DPN 
TPNH pyruvate DPNH 
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In this way LDH is able to regulate metabolic processes by 
controlling the flow of electrons, a function attributed to 
transhydrogenase already mentioned in SECTION I (p.'7 ). 
However, the quantitative significance of this LDH function 
in the uterine cells is still not certain in view of the 
criticism of Stein, Kaplan & Ciotti (1959) that only a small 
amount of transhydrogenation is mediated by LDH. The fact 
that DPN /DPNH and TPN /TPNH ratios, in the uterine tissue 
after oestrogen treatment, do not change correspondingly an d 
in opposite directions diminishes the possibility that 
transhydrogenation is taking place to a significant extent, 
either by the action of LDH or by transhydrogenase (see 
SECTION III, p. 64). 
The physiological significance of G6PDH and 
6PGDH for growth processes could possibly be related to 
their dependence on TPN. Their functioning is responsible 
for the production of reduced TPN which appears to be a 
specific reductant for many biosynthetic processes (Horecker 
& Hiatt, 1958; Dickens et al, 1959). A slight increase 
in TPNH concentration in rat uteri obtained after oestrogen 
treatment has been discussed in relation to uterine levels 
of TPN -linked dehydrogenases (SECTION III, p. 66). In 
addition in tissues containing high activity of the 
hexosemonophosphate ('shunt') enzymes, pentose phosphate, 
-93- 
required in the biosynthesis of nucleotides and nucleic 
acid could come from the direct oxidative decarboxylation 
of glucose -6- phosphate ( Glock & McLean, 1958). It thus 
appears logical that there should be only minimal activities 
of G6PDH and 6PGDH in the atrophic castrate rat uteri, and 
that their levels should be increased 6 to 8 fold following 
growth induced by the administration of oestrogen. It is 
interesting that the levels of G6PDH and 6PGDH in uteri of 
'normal' rats or castrate rats 4 days after oestrogen 
treatment, although they are much lower than those in the 
mammary gland at the height of lactation, are generally 
higher than those in adrenal or liver (Table IV. 5). On 
the other hand, similar enzymic levels in the castrate rat 
uteri are low, and almost in the same range of the levels in 
the non -lactating mammary gland. High levels of G6PDH and 
6PGDH are known to be associated with tissues involved in 
active biosynthesis. For example, Glock & McLean (1958) 
report a 40 fold increase in G6PDH and 10 fold increase in 
6PGDH activities in the rat mammary glands from the start of 
pregnancy to the height of lactation. These increases are 
concluded to be associated with milk production. The high 
activities in the adrenal glands of the two enzymes just 
mentioned (Glock & McLean, 1954; Kelly, Nielson) Johnson 

































































































































































































































































































































































































































































































































































































































































































































































































































































































- 94 - 
TPNH required for adrenocortical steroid biosynthesis (Grant 
& Brownie, 1955). When adrenocorticotrophic hormone (ACTH) 
is administered to human subjects, causing adrenal growth 
and increases in steroid production, an increase in G6PDH 
and 6PGDH activity has been demonstrated (Studzinski, 
Symington & Grant, 1960). In view of these considerations 
it seems reasonable to assume that the increase in levels of 
G6PDH and 6PGDH in the uterus in response to administered 
oestrogen is to provide an environment favourable to 
biosynthetic processes associated with growth. 
It must be pointed out that the assays of 
enzymic levels in this investigation, are carried out under 
optimal conditions, i.e. in the presence of excess of 
substrates and coenzymes. In the rat uterus concentrations 
of di- and triphosphopyridine nucleotides are shown here to 
be low (see SECTION III) and endogenous substrates having 
TPN linked dehydrogenases are also found to be low (Scott 
& Lisi, 1960). Racker (1954) suggests that in steady states 
in cells, concentrations of intermediates (substrates) are 
well below those required to saturate the enzymes. Conditions 
are therefore such that enzymes, using the same substrate, 
are competing for substrate rather than the reverse. A 
large increase in the activity of G6PDH thus greatly enhances 
the ability of the enzyme to compete for its substrate, 
-95- 
glucose -6- phosphate. This may result in a shifting of the 
oxidation of glucose from glycolysis towards hexose 
monophosphate 'shunt' pathway. The pathway of glucose 
oxidation followed in the uterus is therefore investigated 
and reported in the next Section. 
SECTION V 
THE EFFECT OF OESTRADIOL ON THE PATHWAYS OF 
GLUCOSE CATABOLISM IN THE RAT UTERUS. 
-96- 
INTRODUCTION 
Glycolysis or the Embden- Myerhof pathway is 
indisputably the main route of carbohydrate metabolism in 
most animal tissues, and the major alternative pathway 
appears to be via the pentose phosphate or hexosemonophosphate 
'shunt' (Racker, 1954; Gunsalus et al, 1955; Dickens, 1955 
and 1958; Horecker & Hiatt, 1958; Dickens, Glock & McLean, 
1959). However the 'shunt' pathway has been shown to be 
actively responsible for glucose catabolism in many tissues 
including the lactating mammary gland (Abraham et al, 1954; 
Glock et al, 1956a), liver (see Dickens et al, 1959), 
corneal epithelium (Kinoshita, Masurat & Helfant, 1956), 
leucocytes (Coxon & Robinson, 1956), bone marrow (Bloom, 
1955) and most endocrine tissues (see Field et al, 1960). 
A general view at present appears to be that the 'shunt' 
pathway is more closely related to biosynthetic rather than 
to energy yielding processes (see p. 12). 
Oestrogen is known to influence glucose 
metabolism. Thus it is reported that uteri from 
ovariectomised rats up to 24 hours after oestradiol 
administration show increases in glucose utilisation, lactate 
accumulation, and oxygen consumption compared with untreated 
ovariectomised animals (Roberts & Szego, 1953). These 
results are interpreted by these workers as a stimulation 
-97- 
of glycolysis by oestrogen. However, it was also found 
in the same investigations that not all glucose 
disappearance can be accounted for by lactate accumulation. 
For instance, when glucose utilisation is still increasing 
in uteri, 24 hours after oestradiol injection, there is a 
marked decrease in the level of lactate produced. This 
may be an indication that the extra glucose is being 
metabolised either more completely, as suggested by Roberts 
& Szego (1953), or by some pathway other than glycolysis. 
The marked increases in the levels of G6PDH and 6PGDH in 
the uteri of castrated rats after oestrogen treatment (see 
SECTION IV, Fig. IV. 1) also indicate that the 'shunt' 
pathway of glucose metabolism in the uterus may be affected 
by oestrogen. It is therefore of interest to investigate 
the 'shunt' activity in the uterus from rats of different 
oestrogenic status. The knowledge of whether oestrogens 
regulate the two pathways of glucose metabolism may throw 
some light on the mechanism of action of these hormones. 
Recently McLeod & Hollander (1961) in a preliminary report 
claim that there is no increase in the 'shunt' activity of 
the castrate rat uterus 24 hours after oestradiol injection, 
compared with castrate rat control. However, this 
observation is not surprising in view of the low levels of 
G6PDH and 6PGDH in the castrate rats 24 hours after 
-98- 
oestradiol administration as reported in SECTION IV (Fig. 
IV. 1). It is therefore still plausible that the 'shunt' 
pathway may be more active in the uterine tissue where 
levels of G6PDH and 6PGDH are high such as found in castrate 
rats, 3 -4 days after oestrogen admiristration. 
It has been realised recently that the re- 
oxidation of TPNH is a factor controlling the activity of 
the 'shunt' (Kinoshita, 1957; Cahill, Hastings, Ashmore 
& Zottu, 1958; Brin & Yonemoto, 1958; McLean, 1959). 
These workers show that marked stimulation of 'shunt' 
activity can be obtained by the addition, to the incubation 
mixture, of (i) substances such as methylene blue or 
phenazine methosulphate, which oxidise TPNH to TPN directly 
(Cahill et al, 1958; Brin & Yonemoto, 1958; McLean, 1959); 
(ii) substances which promote TPNH utilisation such as 
insulin, which increases the rate of fatty acid biosynthesis 
(Abraham, Cady & Chaikoff, 1957; McLean, 1959), in the 
process of which TPNH is oxidised to TPN (Hele, 1958); 
(iii) substances which Promote transhydrogenation and 
presumably re- oxidise TPNH, e.g. pyruvate (Kinoshita, 1957; 
see also p. 91 ). It is therefore interesting to investigate 
if the 'shunt' activity in the rat uterus can be stimulated 
by these substances. 
The hexosemonophosphate shunt is known to 
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proceed unaffected by iodoacetate, iodoacetamide or 
fluoride ion which inhibit glycolysis completely (Dickens 
& Glock, 1951). The extent of glucose utilisation in the 
rat uterus in the presence of any of these inhibitors may 
indicate the relative activity of the 'shunt' in this 
tissue compared with glycolysis. The results obtained 
may be compared with those from experiments with 
isotopically labelled glucose. 
Various methods have been devised for 
determining the relative importance of the glycolytic and 
'shunt' pathways in the catabolism of glucose by tissues. 
One method involves the use of glucose specifically 
labelled with 14C in position 1 or 6. The theoretical 
basis of this method is that in glycolysis, glucose molecules 
yield two similar C3 fragments and therefore both the C -1 
and C -6 of glucose molecules suffer the same fate. They 
are equally oxidised to CO2 via the Kreb's citric acid 
cycle. On the other hand, in the hexosemonophosphate 
'shunt', the C -1 of glucose is removed as CO2 in the first 
three enzymic steps while the C -6 will be oxidised to CO 
2 
only after recycling. C -1 of glucose is therefore oxidised 
to CO2 at a faster rate than C -6, assuming a slow recycling 
process, which is in fact found in most tissues. It thus 
appears that the ratio of 4CO2 liberated from the oxidation 
-100- 
of Glucose -1 -4C and Glucose -6- 4C (called the C -1 /C-6 
quotient) is 1 if glycolysis is the sole catabolic pathway. 
Ratios higher than 1 are usually interpreted as an indication 
that the 'shunt' pathway is operating in the tissues 
concerned. Due to the simplicity and convenience of this 
method it is most widely used in comparing the significance 
of the two pathways of glucose catabolism in many tissues. 
Other methods which have been employed are much more 
complicated and difficult to carry out. These methods 
involve the measurement of the incorporation of 4C (from 
specifically labelled glucose) into lactate, fatty acids, 
acetoacetate, etc., and the relative contribution of the 
glycolytic and 'shunt' pathways is calculated in a rather 
complicated fashion. It must be pointed out that the 
precise quantitative evaluations of results obtained by 
most methods employed so far are difficult and open to 
criticism due to the uncertainty of assumptions made in the 
calculations (Wood, 1955). At best, the results obtained 
can be considered as an indication of the relative activities 
of glycolytic and 'shunt' pathways. 
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PLAN OF II'VESTIGATIONS 
The present investigation was intended to be 
of a preliminary nature only, and no attempt was made to 
evaluate precise quantitative significance of the two 
pathways of glucose catabolism already mentioned. 
Uteri from (a) intact rats (i.e. 'normal' rats, 
see definition, p. 48), (b) ovariectomised rats untreated, 
and (c) ovariectomised rats 3 -4 days after oestradiol 
administration, were incubated with either glucose -1 -14C 
or glucose- 6-14C. CO 
2 
evolved from the incubation was 
trapped in alkali and precipitated as Ba14CO3, the 
radioactivity of which was measured. It was thus possible 
to compare the C -1 /C -6 quotients obtained with uteri from 
animals of different oestrogenic status. The effects of 
phenazine methosulphate, insulin and iodoacetamide on the 
oxidation of C -1 and C -6 of glucose in these three different 
types of uterine tissues, (a), (b) and ( 
studied. 
have also been 
The rates of glucose utilisation and 02 
consumption of uteri of rats (b) and (c) described above 
were compared with those of Robert & Szego (1953) who 
report marked increases in these rates up to 24 hours after 
a single administration of oestradiol. 
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EXP -I 1101 AL 
The Animals and Operations were similar to 
those described in SECTION III (p. 50). 
Oestradiol injections 
0.1 ml of a solution containing 10 µg oestradiol 
in sesame oil was injected subcutaneously into the castrated 
rats. The injections were repeated daily for 3 -4 days as 
stated in the text. 
Preparation of chopped tissue 
Rat uteri were removed, cleaned and small 
portions were reserved for dry weight determination as 
described in SECTION III (p. 50 ). The uteri were then 
placed on a small cooled plastic disc sitting on the 
chilled metal platform of a Mcllwain Tissue Chopper (H. 
Mickle, Gomshall, Surrey; see Mcllwain, 1961) and chopped 
transversely with the slice thickness setting adjusted to 
0.25 mm. Usually chopped tissue from a number of uteri 
were pooled togetherand 100 -200 mg. portions were weighed 
into each incubation vessel. 
Incubation with radioactive glucose 
Glucose -1 -14C and glucose -6- 4C were obtained 
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from the Radiochemical Centre, Amersham. They were diluted 
with carrier glucose to give a specific activity of 50 µc 
per mmole. A solution containing 100 p moles (5 µc) glucose 
per ml was prepared. Of this solution 0.05 ml volumes were 
delivered, by means of automatic pipettes, into a series of 
boiling tubes (1" X 4.5 ") containing chopped uterine tissue 
suspended in 2.5 ml of freshly made Krebs- Ringer bicarbonate 
solution (Umbreit, Burris & Stauffer, 1957). Other reagents 
(0.1 ml of stated quantities of hormones, dyes, etc.), when 
indicated, were added at this stage. 
After gassing each tube for 1 minute with 
02:CO2 (95 :5) mixture, all tubes were closed tightly with 
rubber bungs, fitted with two glass tubes, as shown at A 
and B in Fig. V. 1. Both the stopcock at A and the screw 
clip at B were kept tightly closed. The tubes were then 
incubated at 370 with gentle shaking for 1 -3 hours. At the 
end of the incubation, they were removed and rubber 
connections at B were attached to 'bubbling tubes' containing, 
5 ml of freshly prepared (CO2 free) 3N. NaOH and the screw 
clip at B opened. One ml portions of 6N. H2SO4 were 
delivered via A to stop the reaction. A very gentle stream 
of N2 was then allowed to sweep through the incubation 
mixture (via A) for at least an hour to ensure a complete 










Fig. V. 1. Apparatus for incubating chopped uterine tissue and the 
'bubbling tube' containing alkali for trapping liberated CO2 (see p0O3). 
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in a preliminary experiment that when the first 'bubbling 
tube' was replaced after 1 hr. by a second tube, and the 
N2 stream continued for a further hour, there was no apparent 
radioactivity trapped in the second tube indicating the 
completeness of absorption of CO2 by the first tube. 
When the bubbling procedure was completed, the 
alkaline solution containing 14CO2 in the 'bubbling tube' 
was transferred quantitatively into 10 ml graduated flasks 
and made up to the mark with CO2-free distilled water. 
solutions were then ready for precipitation with BaC12. 
Precipitation 
The techniques described in 'Handbook of Isotope 
Tracer Method' (ed. W. Sakami) were followed. 
The apparatus shown in Fig. V. 2 was used in the 
precipitation of the absorbed 14CO2 as Ba 14CO3. Two ml of 
0.2 M BaC12 solution (CO 
2 
free) was introduced into the 
stainless steel tube sitting tightly on a weighed filter 
paper which, in turn, was sitting on a flat sintered glass 
filter fitted to a flask with connection to a water pump. If 
suction is not applied this solution does not pass through 
the filter. Four ml (in duplicate) of the alkaline solution 
containing 14CO2 were then added slowly and with stirring 
(continued for 1 minute). After the addition was completed,', 
1.8 CM. 
STAINLESS STEEL TUBE 
FILTER PAPER 





Fig. V. 2. Apparatus used for the precipitation of 1a1 003 as Ba14003 
(see p 104). 
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a further 1 minute was allowed before the pump was started. 
The Ba14CO3 precipitate collected on the filter paper was 
well washed with CO2 freè- distilled water, and sucked dry 
by the pump before removal and drying under an "Angle Poise" 
lamp with a 60 watt bulb at a distance of 30 cm. A heavy 
metallic ring was carefully placed on the rim of the filter 
paper containing precipitates to prevent curling up. When 
dry the weights of the precipitates were determined so that 
corrections for radioactivity self -absorption could be made 
on individual precipitates. The area of the precipitate 
L 
on the filter paper disc was 2.5 cm. and precipitates of 
about 4 mg /cm2 were normally obtained. The filter papers 
containing radioactive BaCO3 precipitate were stuck on to 
plastic planchets with the help of a glue (Durofix). When 
dry, the preparations were ready for radioactivity 
measurement. 
Radioactivity measurements 
Radioactivity was measured using the 'micromil' 
window of an automatic counter (Nuclear, Chicago). 
A self- absorption curve for the counter was 
made by plotting the radioactivity measurements of a series 
of Ba14CO3 precipitates, obtained by precipitation of BaC12 
with Na214CO3 solutions (Radiochemical Centre, Amersham) 
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containing the same amount of radioactivity but an increasing 
amount of Na2CO3 carrier, against their "thickness" (mg /cm ). 
Fig. V. 3 shows that the 'infinite thickness' value for the 
counter employed is more than 50 mg /cm2 which is rather high. 
It was thus decided to count Ba14CO3 precipitates of thin 
,thickness (3 -5 m /cm2), so that the high dilution of the 
radioactivity and the difficulty in making 'infinite 
thickness' preparations would be avoided. Three separate 
self- absorption curves (covering thicknesses of 1 to 5 mg /cm2) 
were prepared as described above, and extensions of the 
graphs to 'zero thickness' were made (Fig. V. 4, tophalf). 
Taking 'zero thickness' readings as 100% activities, (i.e. 
no self- absorption), 'correction graphs' for self -absorption 
were then made by plotting % radioactivity against 'thickness' 
of the precipitates (Fig. V. 4, lower half). The mean value 
of the slopes of the three 'correction graphs' was used as a 
standard graph for correcting all radioactivities of BaCO3 
preparations to activities at 'zero thickness' (usually 
expressed in a final form as counts per min. (cpm) per mg. 
dry uterine weight). 
Oxygen consumption determination 
Oxygen consumption was determined by the usual 
Warburg technique (Umbreit et al, 1957). The main 
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containing the same amount of radioactivity but an increasing 
amount of Na2CO3 carrier, against their "thickness" (mg /cm2). 
Fig. V. 3 shows that the 'infinite thickness' value for the 
counter employed is more than 50 mg /cm2 which is rather high. 
It was thus decided to count Ba14CO3 precipitates of thin 
thickness (3 -5 m /cm2), so that the high dilution of the 
radioactivity and the difficulty in making 'infinite 
thickness' preparations would be avoided. Three separate 
self- absorption curves (covering thicknesses of 1 to 5 mg /cm 
were prepared as described above, and extensions of the 
graphs to 'zero thickness' were made (Fig. V. 4, tophalf). 
Taking 'zero thickness' readings as 100% activities, (i.e. 
no self- absorption), 'correction graphs' for self -absorption 
were then made by plotting % radioactivity against 'thickness' 
of the precipitates (Fig. V. 4, lower half). The mean value 
of the slopes of the three 'correction graphs' was used as a 
standard graph for correcting all radioactivities of BaCO3 
preparations to activities at 'zero thickness' (usually 
expressed in a final form as counts per min. (cpm) per mg. 
dry uterine weight). 
Oxygen consumption determination 
Oxygen consumption was determined by the usual 
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FOR SELF -ABSORPTION 
SLOPE = 7.4 
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Fig. V. 4. Showing (top) self -absorption 
of Ba 4CO3, the slope of which was used in 
constructing a correction graph for self - 
absorption (bottom) (see p 106). 
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compartment of the flasks contained weighed (100 -200 mg), 
chopped uterine tissue in 2.5 ml of freshly prepared Krebs - 
Ringer phosphate solution. The side arm contained 0.3 ml 
of glucose solution (5 ¡moles) and, when stated, other 
reagents (iodoacetamide, coenzyme, etc.). The gas phase 
was air. The oxygen consumption was followed for 1 -3 hours, 
and results were expressed as µl per first hour per mg dry 
weight. 
Glucose utilisation measurement 
The remaining glucose in the mixture after the 
incubation was determined by the glucose oxidase method 
(Huggett & Nixon, 1957) with reagents supplied by Boehringer, 
Mannheim, Germany. Briefly, 1 ml of incubation mixture was 
added to 3 ml of 4% perchloric acid, and the precipitated 
proteins were centrifuged down and discarded. A 0.2 ml 
volume of the supernatant was then mixed with the 'glucose 
reagent' (contained glucose oxidase, peroxidase and o- 
dianisidine hydrochloride, in phosphate buffer, pH 7) and, 
after 35 min. standing at room temperature, the brown 
colour developed was measured at 436 mµ, using a Unicam 
SP500 spectrophotometer. The amount of glucose in the 
solution was then calculated from a calibration curve 
prepared with each set of determinations. Glucose 
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utilisation was then obtained by subtracting the remaining 
glucose quantity from the starting value. It was expressed 
as µmoles glucose used per hour per g. dry weight. 
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RESULTS 
(i) Determination of the rates of glucose and 
oxygen utilisation in the rat uterine tissue. 
The rates of glucose and 02 utilisation by 
uteri of ovariectomised untreated rats and of similar 
animals after 4 daily subcutaneous injections of 10 µg 
oestradiol were determined. Results summarised in Table 
V. 1 show that the rates of both glucose and 02 utilised 
in uteri from oestrogen treated animals are increased over 
the control values by 37% and 239% respectively. 
(ii) The oxidation of labelled glucose by rat 
uterine tissue. 
Results summarised in Table V. 2 show that 
C -1 glucose is oxidised to CO 
2 
at a slightly faster rate 
than C -6, in the uteri from all types of animals 
investigated. Generally, the shorter incubation periods 
(1 hour) give higher C -1 /C -6 quotients than the longer 
periods (3 hours). However, the differences are only 
small and it is shown in Fig. V.5 that 14CO2 production 
increases, after the initial time lapse, directly with the 
time of incubation. 
It may be noted from Table V. 2 that C -1 /C -6 
quotients per uteri from untreated ovariectomised control 
Table V. 1. 
The rates of glucose utilisation and oxygen consumption in the uteri 
from ovariectomised rats with and without oestradiol injection. The 
incubation mixtures contained 100 -200 mg of chopped uterine tissue, 
5 µmole of glucose, 2.5 ml of Krebs -Ringer phosphate solution, pH 7.4 
Results shown are mean values from two separate determinations. 
Ranges of the differences from means are also shown. 
Types of rats 
Glucose Utilisation 02 consumption 
µmole /3 hr /g dry wt. µl/hr/mg dry wt. 
OVX 
OVX + OD 
** 














OVX = ovariectomised 
** 
OD = oestradiol 
Table V. 2. 
14CO2 recovered from the incubation of 5 µmole of either glucose -1 -14C 
or glucose -6 -14C with 100 -200 mg of chopped uterine tissue suspended in 
2.5 ml freshly prepared Krebs -Ringer bicarbonate buffer, pH 7.4. The 
gas phase was 02:CO2-95:5. Results shown are means (expressed as c.p.m. 
at zero thickness per mg dry weight) with S.E.M. 
Types of rats 
1 hr. incubation period 3 hrs. incubation period 
o.of* 
pt. C -1 C -6 C -1/C -6 
No.of 
apt, C -1 C -6 C -1 /C -6 
' Tormal' 2 91 + 31 38 4- 4 2.4 5 220 + 20 112 + 19 2.0 
OVX* 5 57 + 6 37 + 6 1.5 5 166 + 29 125 + 16 1.3 
** 
OVX + OD daily 
for 3 days 6 73 + 16 39 + 5 1.9 4 281 ± 18 168 + 16 1.7 
OVX + OD daily 
for 4 days 3 77 + 2 44 ± 5 1.8 5 248 + 28 154 ± 18, 1.6 
* 
OVX = ovariectomised 
** 
OD = oestradiol 
* * *C -1, C -6 denote 14CO2 from the oxidation of 0 -1 and C -6 of 
glucose molecules respectively. 
50 
40 
- A GLUCOSE -I-it 
-111 GLUCOSE -6jC 
O 1 2 
hr. OF INCUBATION 
3 
Fig. V. 5. The relationship between the time of incubation 
and CO2 liberated from the oxidation of glucose (labelled 
with l C at either C -1 or C -6) by chopped rat uterine tissue. 
Similar results were obtained with uteri from either 'normal' 
or castrate rats, with and without oestrogen treatment. 
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rats are the lowest, compared with other results. Uteri 
from the oestrogen -treated ovariectomised animals appear 
to show an increase of 20-40% in the overall oxidation of 
both C-1 and C -6 of glucose as compared with the controls. 
However a considerably faster rate of increase is observed 
in the oxidation of C-1 as compared with C-6. As a result 
of this, higher C -1 /C-6 quotients are obtained with those 
oestrogen treated ovariectomised rats compared with the 
controls. 
The quotients observed with the uteri from 
'normal' rats are slightly higher than those from oestrogen 
treated rats, again as a result of higher oxidation of C -1 
than of C-6 of glucose molecules. It must be pointed out 
that those results should only be regarded as an indication 
of a trend because they are not statistically significant. 
(iii) In' its effects of oestradiol, phenazine 
methosulphate, insulin and iodoacetamide, on the uterine 
oxidation of labelled glucose. 
Results summarised in Table V. 3 show that 
in the 'normal' rat uteri, oestradiol suppresses the 
oxidation of both C -1 and C -6 of glucose to about the same 
extent. The degree of suppression depends on the 
concentration of the oestrogen in the mixture. It is also 
Table V. 3. 
Effects of oestradiol, phenazine methosulphate, insulin and iodoacetamide 
on the amount of 14002 recovered from the incubation of labelled glucose 
with rat uterine tissue. Reaction mixtures are the same as described in 
Table V. 1. Results are expressed as percentages of control. 






OVX rats + OD 
daily for 4 days 
C -1 c-6 c-1 c-6 C -1 C -6 
nil - control 100 100 100 100 100 100 
3 X 10 5M oestradiol 79 90 - - - - 
20 X 10 5M oestradiol 47 39 - - - - 
10 4M phenazine methosulphate - - 980 166 861 217 
- - 966 248 
Insulin (1 i.u. /2.5 ml) - - 132 131 130 107 
109 120 133 147 
10 4M iodoacetamide 2.1 4.1 - - - - 
- 6.5 
* 
OVX = ovariectomised 
** 
OD = oestradiol 
* * *C -1, C -6 denote 14CO2 from the oxidation of C -1 and C -6 of 
glucose molecules respectively. 
shown that in the uteri of similar animals, iodoacetamide 
at the concentration chosen inhibits the glucose oxidation 
almost completely (93 -98 %). The inhibitions of oxidation 
at C-1 and C -6 by iodoacetamide are probably equal. In 
uteri of castrate rats, either with or without oestrogen 
treatment, phenazine methosulphate stimulates C-1 oxidation 
9 -10 times and C -6 oxidation by about twice. On the other 
hand, in tissues from similar animals insulin appears to 
stimulate the oxidation of C -1 and C -6 to a small extent 
(20 -30%) . 
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DISCUSSION 
It has been demonstrated in the present 
investigation (Table V. 1) that uteri removed from castrate 
rats 4 days after the start of oestradiol injections show 
increases in the rate of glucose (determined enzymically) 
and oxygen consumption, as compared with the controls. 
The increases are similar to those observed up to 24 hours 
after oestrogen administration (Roberts & Szego, 1953). 
The increase in glucose metabolism is also observed in 
measurements made with radioactive labelled glucose. Thus, 
the radioactivity of 14CO2 recovered from the incubation 
of uterine tissues obtained 3 -4 days after oestrogen 
administration is higher than that observed with uteri of 
similar animals not receiving oestrogen. Similar results 
are obtained by both methods. 
The fact. that the uteri of rats treated in 
different ways gave a C -1/0 -6 quotient not differing greatly 
from unity, and that iodoacetamide almost completely 
inhibits glucose oxidation, indicates that glycolysis is 
the main catabolic pathway of glucose in the rat uterus. 
Nevertheless, some hexose phosphate 'shunt' activity is 
indicated even in the uteri from ovariectomised rats (which 
show the lowest C -1 /C -6 ratio), since the oxidation of 
C -1 of glucose is faster than of C -6 (Table V. 2). The 
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slightly lower C -1 /C-6 quotients obtained when the incubation 
time is prolonged may be due to a more extensive recycling 
process in the 'shunt' pathway during the longer incubation. 
Similar observations have been reported in the study with 
thyroid tissue (Dumont, 1960). 
The finding that the oxidation of C -1 of glucose 
is increased more than of C-6 in uteri from oestrogen- 
treated castrate rats, although only of limited significance, 
may indicate a tendency to increase the 'shunt' activity in 
the oestrogen treated tissue. The fact that phenazine 
methosulphate stimulates the oxidation of C-1 of glucose to 
a much greater extent than of C -6 shows that the re- oxidation 
of TM may be an important factor in controlling the activity 
of the 'shunt.' Since TPIIH is likely to be utilised in 
vivo in the growing uteri of oestrogen -treated castrate 
rats more than in the atrophic control uteri, one can 
imagine more glucose being metabolised via the 'shunt' 
pathway in the first case than in the latter. The small 
increase in the 'shunt' activity in the uteri of oestrogen 
treated animals (as seen from the increase in the C -1 /C-6 
quotient observed in vitro) may thus be of more significance 
in vivo where biosynthetic processes are proceeding at an 
optimum pace. The in vitro incubation, as done in this 
investigation, with glucose as the sole substrate, may not 
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represent the right conditions for a substantial rate of 
biosyntheses. It is therefore possible that the uteri of 
oestrogen treated animals metabolise glucose via the 
hexosemonophosphate pathway to a greater extent in vivo 
than is indicated by the in vitro measurements now reported. 
Insulin appears to stimulate the oxidation of 
both C-1 and C-6 to about the same extent, indicating that 
this hormone promotes glucose metabolism by the two pathways, 
either to the same degree, or at an early common stage of 
the two routesaas for example by increasing cell permeability 
to glucose or by activating hexokinase (see Fisher, 1960). 
The ability of insulin to stimulate the C -1 oxidation in 
the mammary glands from lactating animals (but not in the 
glands from pregnant rats) (McLean, 1959), is attributed 
to the fact that the hormone increases the in vitro 
synthesis of fatty acids from glucose (Balmin, Folley & 
Glascock, 1954; Abraham, Cady & Chsikoff, 1957). However, 
since insulin does not stimulate the oxidation of C -1 of 
glucose in uteri from rats receiving oestrogen to a greater 
extent than in the uteri from the untreated animals, this 
may indicate either the inactivity of hexosemonophosphate 
shunt in the uterus, or the inability of insulin to 
stimulate the TPNH - reoxidising system in this tissue. 
It may be pointed out that the biosynthetic processes in 
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the lactating mammary glands, where milk production is 
predominant, and in the proliferating rat uterus are not 
of the same nature, and may not be influenced by insulin 
in the same fashion. 
It is interesting that there is only a slight 
tendency to increase the activity of the hexosemonophosphate 
'shunt' in uteri from castrate rats 3 -4 days after the 
oestrogen administration, in spite of the very marked 
increases in the levels of G6PDH and 6PGDH (see SECTION IV). 
It is known, however, that increases in these two enzymes 
may not necessarily be accompanied by a corresponding rise 
in the 'shunt' activity, and an increased participation of, 
glycolysis may even be obtained. For instance, the levels 
of both G6PDH and 6PGDH in the liver of thyroxine- treated 
rats are increased significantly ( Glock & McLean, 19550), 
yet only the glycolytic pathway is found to be stimulated; 
the 'shunt' activity appears to be unaffected ( Glock et al, 
1956b). It is not yet know whether there is any increase 
in the level of phosphoglucose isomerase (the enzyme in the 
glycolytic pathway which competes with G6PDH for glucose -6- 
phosphate) in the uteri from castrate rats after a similar 
period of oestrogen administration. Information concerning 
this enzyme may be critical because the increase in the 
level of phosphoglucose isomerase could counteract most of. 
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the increase in the level of G6PDH and result in only a 
small overall increase in the 'shunt' activity. Glucose - 
6- phosphate can be metabolised in a number of different ways, 
and it has been shown, with liver slices, that the pattern 
of metabolism is influenced by changes in cationic 
concentrations in the incubating medium, or by using liver 
from diabetic rats (Ashmore, Cahill, Hastings & Zottu, 
1957). A similar comprehensive investigation of the 
effect of oestrogen on the pathways of glucose metabolism 




In the present investigation, two main 
approaches were made in a study of the mechanism of action 
of steroid hormones, on the assumption that the hormones 
produce their biological effect either by participating in, 
or by specifically affecting some enzyme systems. 
The first approach is an attempt to obtain 
further support for the postulation of Villee and Talalay 
that a transhydrogenase, such as that found in human 
placenta, is the locus of steroid action. 
Before assessing the problem in the light of 
the new findings reported in this thesis, let us survey the 
merits of the transhydrogenase theory. The most novel 
aspect of this theory is that it offers a very clear cut 
explanation of the effect of oestrogenic hormone added in 
low concentration (10 
8 
- 10 6i.ß) to an in vitro system. 
The concentration of hormone used is within the range that 
one might conceive to be present in the tissues (see Engel 
& Scott, 1960). Furthermore, the effects of various 
oestrogens on the placental transhydrogenase are roughly 
parallel to their biological activities. Oestradiol and 
oestrone have a strong stimulating effect, oestriol 
possesses a much weaker effect, and oestradiol -17L and 
many other steroids are completely devoid of effect on the 
transhydrogenase system. The apparent lack of effect on 
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transhydrogenase of potent synthetic oestrogens such as 
diethylstilboestrol, was a serious objection to the validity 
of this theory. It has recently been shown, however, by 
Glass, Loring, Spencer ßc Villee (1961) that these substances 
do in fact stimulate the enzyme. Very low concentrations 
of stilboestrol must however be used, because concentrations 
higher than 3.7 X 10 
6IA 
cause inhibition. The failure of 
the earlier attempts were due to the use of too high 
concentrations. Another merit of the theory is that it 
enables one to visualise the role played by oestrogen in 
its specific and controlling effect upon metabolic processes 
(see p. 7). These observations are consistent with the 
view that the effect of oestrogen on transhydrogenase can 
explain their biological activity but are by no means proof 
that this is the case. 
The most disturbing feature of Villee's 
transhydrogenation theory is the apparent absence of the 
oestrogen -sensitive transhydrogenase activity in the known 
'sites' of action of oestrogen such as in the human 
endometrium, rat uterus and vagina and chicken oviduct, etc., 
as shown in SECTIONS II and III of this thesis. An 
endogeneous inhibitor may be present in these tissues (p. 42), 
and this may prevent the in vitro demonstration of 
transhydrogenase activity, but one fails to see any 
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physiological importance of the transhydrogenation system 
to the cells concerned under such a condition. It is 
of course quite possible that this inhibitor does not come 
into effect in vivo. Indeed one of the most important 
tasks for the future is to examine the nature of this 
inhibition. In view of the fact that similar negative 
results are obtained when both in vitro (SECTION II) and 
in vivo (SECTION III) techniques are employed in the 
investigation of transhydrogenation in the rat uterus, it 
seems unlikely that the failure to demonstrate transhydro- 
genase activity is due to inappropriate experimental 
conditions. It is more probable that the enzyme is absent 
from the tissues. 
Apart from the human placenta, the oestrogen - 
activated transhydrogenase has been shown only in one other 
'target' organ, namely the human breast (Hollander et al, 
1958). But even in this tissue, only 46.9 per cent of 
the specimens examined by Hollander (1958) showed sensitivity 
towards oestrogen. A fact of this kind is unexpected, 
since, unless some other limiting factor is operating, all 
normal breast tissue should be sensitive to oestradiol. 
It is difficult to imagine a key enzyme to be present in 
less than half of the samples examined while it is known 
that breast tissue invariably responds to oestrogen 
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stimulation. 
The physiological significance of the presence 
in the human placenta of an oestrogen -sensitive 
transhydrogenase, can be questioned on the grounds that the 
placenta is hardly a typical 'site' for oestrogen action. 
There is no particular evidence that an oestrogen plays a 
physiological role in placental tissue as it does in more 
characteristic target tissues. During the major part of the 
life span of a woman, the placenta does not exist in her 
body and may never do so if she is not to bear a child, 
although she will enjoy all the feminine characteristics, 
reflecting the normal functioning of her oestrogenic 
hormones. The placenta arises partly from the endometrium, 
and partly from the foetus. Its growth parallels that of 
the foetus, and it is expelled from the maternal body at 
term. It is not too far from fact to state that the 
placenta, like the foetus is 'external' to the maternal 
body. It is therefore perhaps unwise to look to a 
phenomenon occurring in a somewhat external tissue as a 
model for the mechanism of action of oestrogen in the normal 
female organism, especially when the evidence for this 
certain phenomenon occurring in most of the usual sites 
of oestrogen in the body cannot be obtained. 
The oestrogen- sensitive transhydrogenase, 
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found in the soluble fraction of human placenta and breast 
tissue, may, as suggested by Mueller (1960, 1961) be 
induced in response to the abnormally high levels of 
endogenous oestrogen supplied to these tissues. This 
elevated supply of oestrogen is certainly true for the 
placenta and may also be true under certain circumstances 
for breast. 
Since the known oestrogenic steroids produce 
similar responses in most species, their in vitro effect 
should not be species- specific. The evidence obtained in 
SECTION II, shows that oestrogen -sensitive transhydrogenase 
does not meet this criterion. Among the placentae from 
6 mammalian species investigated, only that from human 
subjects is found to contain this enzyme. This further 
stresses the danger of attempting to generalise effects of 
hormones between, not only different tissues, but also 
similar tissues from different species. 
With regard to the quantitative significance 
of the human placenta and breast transhydrogenase, even 
at the maximum oestrogen stimulation the enzymic activity 
is much lower (about a tenth) than the mitochondrial 
transhydrogenase (Villee et al, 1960) of the same tissue, 
whose activity is already small compared with similar enzyme 
activity in some tissues such as heart (Humphrey, 1957). 
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Stein & Kaplan (1959) have in fact suggested that the term 
transhydrogenase be reserved for the more active 
mitochondria) enzyme. Although the suggestion is rather 
unfair in view of the true transhydrogenation catalysed by 
the placental soluble enzyme, the difference between the 
activities of the two enzymes remains striking. As Villee 
et al (1960) point out, if the role of transhydrogenase is 
to produce DPAH, the oxidation of which is coupled with 
phosphorylation to yield ATP, then the soluble enzyme enjoys 
the more abundant supply of TPNH, since the two major TPN 
reducing enzymes G6PDH and ICDH are located in the soluble 
part of the cytoplasm. However, this advantage, due to 
cellular compartmentation, is rather doubtful in view of 
the fact that the oxidation of DPNH occurs in the 
mitochondria. Moreover, under the most favourable 
conditions produced in vitro transhydrogenation catalysed 
by the soluble human placental enzyme is much weaker than 
that effected by the mitochondrial enzyme. The 
physiological significance of this weak transhydrogenation, 
for energy production is very questionable when a more 
powerful enzyme system is available. 
Thus it appears that in spite of the attractive. 
aspects of the transhydrogenase theory for the mechanism of 
action of oestrogens, it is not without drawbacks. It may 
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be pointed out here that these difficulties are equally 
true whether we accept Villee's view that oestrogens 
"activate" the transhydrogenase in some manner unknown 
or Talalay's that the oestrogens act as coenzymes (p. 6, 
see also p. 44). 
Although the transhydrogenase theory cannot, 
at present, be accepted as the answer to the problem of 
mechanism of oestrogen action, the idea of oestrogen 
influencing some enzyme can still be regarded as an 
attractive working hypothesis. Thus it is possible that 
the 'target' organs, by embryonic differentiation differ 
from the 'non- target' organs in one or more enzymes, with 
unique responsiveness to hormonal stimulation. As a 
result of this stimulation, key metabolites may accumulate 
and promote or induce other enzymic reactions (common to 
both 'target' and 'non -target' tissues) leading to 
characteristic responses such as growth. It is thus 
Possible to have characteristic responses at the 'site' 
of action of a hormone, but not in other tissues. The 
identification of such an enzyme (or enzymes) in endometrium, 
uterus and pituitary (see p.40), which respond to oestrogens 
added in vitro by an increase in oxygen consumption by 
those tissues, would be interesting because of the 
possibility that it may prove to be the specific enzyme 
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discussed above. 
The second approach to the study of the 
mechanism of action of oestrogenic steroid hormone, chosen 
in the present investigation, involves the pretreatment of 
the experimental animals with the hormone, and subsequent 
removal of a suitable 'target' tissue for comparison of 
its biochemical reactions with those of the tissue from 
an untreated animal. Since the system employed here, 
unlike the single enzyme transhydrogenase already referred 
to, is very complex and cannot be readily defined 
biochemically, the differences between stimulated and 
unstimulated tissues, when obtained, may be due either to 
a primary or a secondary effect of the hormone concerned. 
However, information obtained from such a study should be 
of value in singling out sequences of biochemical reactions 
influenced by administered oestrogen, and by tracing these 
back in time it might well be possible to identify the 
locus of the initial action of the hormone. The 
biochemical parameters chosen for study here - namely the 
concentrations of oxidised and reduced pyridine nucleotides, 
the levels of pyridine nucleotide -linked dehydrogenases 
and the metabolic pathways of glucose in the rat uterus, 
represent only a few aspects of the biochemical activities 
of the cell. Nevertheless, the results obtained have 
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certain features in common with those from a similar study 
of different enzymic systems by Mueller. Thus marked 
increases in the levels of G6PDH, 6PGDH and LDH in the 
uteri from oestrogen treated rats (SECTION IV) are considered 
to increase the production of DPÎH and TPIVH (p.p. 66 and 91), 
presumably required in the stimulated anabolic processes 
concerned with the synthesis of protein, nucleic acids and 
lipids occurring in the proliferating uterus. (Mueller et al, 
1958; Mueller, 1960 and 1961). This view is supported by 
the fact that the concentrations of DPEH and, to some extent, 
of TPII{ increase at the same time as the increases in the 
levels of the dehydrogenases (SECTION III). The increases 
in the oxygen and glucose utilisation by the stimulated 
uteri, including a tendency to increase the glucose 
catabolism via the hexosemonophosphate 'shunt', also indicate. 
an increase in the supply of energy and intermediates (e.g. 
ribosephosphate) to the growing tissue. These observations 
are in accord with the view that oestrogen is affecting 
the uterine cells by modifying the environment in such 
a way that many biosynthetic processes are facilitated 
with the resultant discernible uterine growth (Fig. I. 1). 
It may be noted that the stimulation of these biosynthetic 
processes are probably brought about by the increases in the 
levels of the enzymes responsible, as distinct from a 
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permeability phenomenon. In SECTION IV (p. 90) some 
evidence is presented that these increases are due to an 
increase in the amount of enzyme protein, synthesised 
de novo, rather than to stimulation of pre -existing enzyme. 
In recent reviews of their studies on the mechanism of 
action of oestrogens Mueller et al (1958), Mueller (1960 & 
1961), arrive at a similar conclusion. This is based on 
two main facts: the inability to activate pre -existing 
enzyme molecules by oestrogen added in vitro, and the 
failure to stimulate biosynthesis of nucleic acid purines 
and pyrimidines and of lipids when protein biosynthesis 
is blocked by puromycin (see Yomolinski & De la Haba, 1959). 
It is interesting that oestrogenic hormones 
are not the only ones in the steroid world whose mechanism 
of action is connected with stimulation of de novo synthesis 
of enzyme protein. Thus Umbreit (1951), who studied the 
influence of cortisone on proline oxidase in kidney and 
D -amino acid oxidase in liver, came to the conclusion 
that the effect of cortisone is apparently upon the amount 
of enzyme present rather than the activation of the hormone.' 
The fact that ethionine (a substance known to interfere 
with protein synthesis by competing with methionine) 
prevents the increase in the level of tryptophan peroxidase 
in the rat liver induced by the administration of cortisone 
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led Knox & Auerbach (1955) to believe that the increase is 
resultant from'the rise in the amount of newly synthesised 
enzyme protein. The increase in the level of 
ß- glucuronidase in the kidneys of mice treated with 
androgens is found by Fishman (1961) to be due to an 
increase in the amount of enzyme protein, based on the 
incorporation of radioactivity from glycine -1 14C 
administered to animals undergoing androgen administration. 
Indeed, in the most recent review on the mechanism of 
action of androgens, Dorfman (1961) proposes that androgens 
act by the stimulation of the rate of biosynthesis of 
specific enzyme protein. It thus appears that, although 
the steroid hormones may differ vastly in their biological 
activity, their mechanism of action may prove to be similar 
in nature. 
Thus it appears that one of the very first 
actions of oestrogen is to 'trigger' off the machinery for 
synthesising specific enzyme protein. At present, just 
how oestrogen brings this about, and why the stimulation 
occurs only in the 'target' organ, are matters for 
speculation. Mueller suggests that the hormone might, 
somehow, remove membranous 'barriers' which cover the 
templates (consisting of a combination of enzyme protein 
and RNA) involved in the enzyme synthesis. It is also 
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necessary to postulate that, due to embryonic differentiation 
established in each type of tissue, only the 'template- 
barriers' in the 'target' organ are capable of responding 
to oestrogenic hormones. It may be noted that this 
speculation is different from the principle involved in 
the transhydrogenation theory (p. 122) in that, instead of 
having a completely new enzyme in the 'target' organ, there 
are the same setsof enzymes in all tissues. They are, 
however, different quantitatively and qualitatively in 
various cells, giving rise to a different response in 
different cells. There is evidence indicating that there 
may be a fundamental difference between the 'target' and 
'non- target' organs. Thus, on injection of tritium - 
labelled oestradiol into young female rats, radioactive 
oestrogenic steroids appear in and are retained by the 
uterus, vagina and pituitary gland longer than those in 
the liver, kidney, muscle, adrenal, blood and bone ( Flesher, 
Gupta, Jacobson & Jensen, 1960). In a similar investigation, 
oestradiol alone is found in the rat uterus, but mixtures 
of conjugated steroids are found in liver (Saha, Flesher, 
Jacobson & Jensen, 1960). It thus appears that there is 
a selective localisation of exogenous steroid in 'target' 
organs. 
In view of the diverse physiological responses 
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described in a variety of species following in vivo 
administration of oestrogen (p. 1), it is Possible that the 
mechanism of action of this hormone may not necessarily be 
limited to orly one. The importance of the compartmental 
nature of the cells for organised functions has been 
realised (Siekevitz, 1959) and it is also known that some 
hormones affect cell membranein such a way that substrate 
or cofactor molecules are more readily available to the 
enzyme and thus increase the overall rate of the specified 
enzyme system. Insulin, for instance, is well established 
that its effect on sugar permeability is Primary to an 
effect of insulin on glucose uptake and metabolism (see 
Levine, 1957). Beside the enzymic approach to the study 
of the mechanism of action of oestrogen, work has also 
been done on the effect of oestrogen on the permeability 
of the uterine cells. Hechter & Lester (1960), who 
measured the distribution of radioactively labelled inulin, 
sucrose, D- xylose, a- aminoisobutyrate, 22Na and 86Rb between 
tissue and cell water, using uterine tissue from 
ovariectomised rats with and without oestrogen treatment, 
found that there are no striking differences in cellular 
permeability to these substances between the two types of 
uteri. These workers conclude that oestrogen does not 
affect the uterine cell membrane to facilitate substrate 
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entry, although they have not ruled out the possibility 
that oestrogen might influence the permeability of only a 
limited number of cells in the uterus. In this connection, 
it is also possible that the hormone might alter the 
permeability of sub -cellular bodies such as of mitochondria. 
In conclusion, it appears that there is no 
evidence available at the present time to permit conclusions 
regarding the primary physical or chemical events at the 
cellular level, which are influenced or regulated by 
oestrogenic hormones, or any other steroid hormones. 
However, the author feels, the future is promising. 
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SUMMARY 
The mechanism of action of steroid hormones, 
in particular of oestrogens, has been investigated along 
two main lines. 
(a) Attempts have been made to assess the 
physiological role of an oestrogen- sensitive transhydrogenase 
first demonstrated in the placenta of women. The original 
observations have been confirmed but it has not been 
possible to demonstrate the same enzyme activity in placentae 
from rat, guinea -pig, rabbit, golden- hamster or pig. Nor 
has the enzyme been found in such oestrogen "target" organs 
as human endometrium, rat and guinea -pig uterus, rat 
vagina, chicken oviduct or ox pituitary. Negative results 
are not due to destruction of substrates or coenzymes during 
the enzyme determinations, but may be due to the presence of 
endogeneous inhibitors. 
The ratios of oxidised to reduced di- and 
triphosphopyridine nucleotides have been determined in the 
uteri of intact, ovariectomised and ovariectomised oestrogen 
treated rats. Changes in these ratios in response to 
oestrogenic steroids give no indication of transhydrogenase 
activity in vivo. 
The inability of some 313- and 11ß -hydroxy 
steroids to act as coenzymes and promote transhydrogenation 
- 132 - 
in the liver and adrenal has also been observed. 
(b) Changes in levels of glucose -6- phosphate 
dehydrogenase (G6PDH), 6- phosphogluconic acid dehydrogenase 
(6PGDH), isocitric dehydrogenase (ICDH) and lactic 
dehydrogenase (LDH) and in concentrations of oxidised and 
reduced di- and triphosphopyridine nucleotides in the 
ovariectomised rat uterus in time in response to oestradiol- 
17ß have been investigated. The concentrations of the 
oxidised pyridine nucleotides remain unchanged, but the 
reduced forms of the coenzymes decrease in concentration 
up to 6 hours after oestrogen administration and then show 
a steady increase until at 72 hours the concentrations are 
significantly higher than in the uteri from ovariectomised 
controls. 
The levels of uterine G6PDH, 6PGDH and LDH are 
increased by oestrogen. That of ICDH shows no change. 
It is suggested that there is an overall 
increase in reduced coenzyme concentration due to the 
increased levels of enzymes concerned but that the initial 
decrease in reduced coenzymes may be related to demands 
for energy and specific reductants for biosynthesis in 
response to oestrogen. 
Some evidence is produced to support the view 
that the increases in levels of enzymes are due to synthesis 
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of new enzyme protein rather than to activation of existing 
enzyme. 
Changes in concentration of G6PDH and 6PGDH 
but not in ICDH suggested the possibility of an effect of 
oestrogen on glucose catabolism. This has been 
investigated using 4C- labelled glucose. In general 
oestrogen is found to stimulate glucose catabolism, the 
increase being mainly via the hexosemonophosphate 'shunt' 
pathway. Glycolysis is however the major pathway of 
glucose metabolism in the uteri of ovariectomised and 
oestrogen treated rats. 
It has also been shown here that the use of 
the 'shunt' pathway is dependent on the rate of reoxidation 
of reduced triphosphopyridine nucleotide. Since this 
reoxidation may Troceed at a greater rate in vivo than 
under the in vitro conditions of the Present experiments, 
the 'shunt' pathway may in fact be of greater significance 
than it has been possible to demonstrate in this 
investigation. 
The probable mechanisms of action of 
oestrogenic hormones are reviewed in the light of the 
results now obtained. It is concluded that the 
transhydrogenase theory of Villee & Talalay is of doubtful 
importance in explaining the action of oestrogens. It also 
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seems likely that oestrogenic hormone is concerned with 
the induction of the biosynthesis of new enzyme protein 
and that this process in some way 'triggers' the whole 
anabolism of the 'target' tissue. 
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APPStDIX I 
Chemicals used 
DPN, TPN, DPNH, TPNH and yeast ADH were 
obtained from Boehringer & Sons, Mannheim- Waldhof, Germany. 
The DPN was assayed by the method of Racker (1950), and 
found to be 94% pure and contained no detectable amount of 
TPN. TPN, DPI!H and TPNH were assayed fluorometrically 
against standard DPN solution from above (see Bassham et al, 
1959). 
G6P (di- potassium salt), 6PG (sodium salt), 
ATP (di- sodium salt), G6PDH (practical type II) and phenazine 
methosulphate were obtained from Sigma Chemical Co., St. 
Louis, U.S.A. 
Oestradiol -17P, oestriol, oestrone, oestradiol - 
17a, progesterone, cortisol, cortisone,DOC- acetate, 
pregnenolone, testosterone, androsterone were obtained from 
the Medical Research Council Steroid Reference Collection 
or from Messsrs. Organon Laboratories Ltd., 
-Newhouse, Lanarkshire. 
2- fluoro -oestradiol -17P was a gift from Dr. 
G. C. Mueller, University of Wisconsin Medical School, 
Madison, U.S.A. 
MLR -25 was a gift from Messrs. Wm. S. Merrell 
& Co., Cincinnati, U.S.A. Amphenone -B was a gift from the 
The Upjohn Company, Kalamazoo, Michigan, U.S.A. 
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DON was a gift from Park Davis & Co. 
Crystalline insulin (6 X recrystallisation) 
was obtained from Boots Pure Drugs Co., Nottingham, 
England. 
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APPENDIX III 
2UBLICATION 
[Reprinted from the Proceedings of the Biochemical Society, 29 June 1960. 
Biochem. J., 1960, Vol. 76, No. 3, 46 r.] 
(11) Effect of Oestradiol -17(3 on the Produc- 
tion of Reduced Triphosphopyridine Nucleo- 
tide in the Rat Uterus. 
By K. MONGKOLKUL and J. K. GRANT.* (Depart- 
ment of Biochemistry, University of Edinburgh) 
The importance of triphosphopyridine nucleo- 
tide in the reduced form (TPNH) in reductive 
biosynthesis is now generally recognized. The pro- 
duction of TPNH in the oestrogen -stimulated rat 
uterus has therefore been studied. 
In the present investigation no significant increase 
in concentration of TPNH in the ovariectomized 
rat uterus could be demonstrated after administra- 
tion of oestradiol -17ß in vivo. Such an observation 
does not, however, preclude an increased rate of turn- 
over of TPNH as might be indicated by increased 
activity of TPNH -generating systems. No evidence 
has been obtained that increased amounts of 
TPNH arise from stimulation of a pyridine nucleo- 
tide transhydrogenase by oestrogen, although this 
effect has been demonstrated in human endo- 
metrium and other tissues (Hagerman & Villee 
1952; Talalay & Williams -Ashman, 1958). 
* Present address: University Department of Steroid 
Biochemistry, Royal Infirmary, Glasgow. 
It has been found, however, that the glucose 
6- phosphate and 6- phosphogluconic acid dehydro- 
genese activities of the uterus in vitro are markedly 
enhanced by administration of oestradiol -17ß to 
castrated rats. This effect is diminished by the 
simultaneous administration of the cytotoxic drug 
DON (6- diazo- 5 -oxo- nor -L- leucine) which is known 
to inhibit uterine growth in response to oestrogen 
(Poulson, Robson & Wander, 1960). The activity of 
isocitric dehydrogenase is uninfluenced by oestrogen 
administration. It is therefore possible that an 
important effect of oestrogen in the uterus is to 
control glucose oxidation by the pentose phosphate 
shunt and thus to influence the availability of 
TPNH and to provide ribose 1- phosphate for 
nucleoside biosynthesis at the same time. 
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